Signaling	O
through	O
the	O
lymphotoxin-beta	B-protein
receptor	I-protein
stimulates	O
HIV-1	O
replication	O
alone	O
and	O
in	O
cooperation	O
with	O
soluble	O
or	O
membrane-bound	B-protein
TNF-alpha	I-protein
.	O

The	O
level	O
of	O
ongoing	O
HIV-1	O
replication	O
within	O
an	O
individual	O
is	O
critical	O
to	O
HIV-1	O
pathogenesis	O
.	O

Among	O
host	O
immune	O
factors	O
,	O
the	O
cytokine	B-protein
TNF-alpha	B-protein
has	O
previously	O
been	O
shown	O
to	O
increase	O
HIV-1	O
replication	O
in	O
various	O
monocyte	O
and	O
T	O
cell	O
model	O
systems	O
.	O

Here	O
,	O
we	O
demonstrate	O
that	O
signaling	O
through	O
the	O
TNF	B-protein
receptor	O
family	O
member	O
,	O
the	O
lymphotoxin-beta	B-protein
(	I-protein
LT-beta	I-protein
)	I-protein
receptor	I-protein
(	O
LT-betaR	B-protein
)	O
,	O
also	O
regulates	O
HIV-1	O
replication	O
.	O

Furthermore	O
,	O
HIV-1	O
replication	O
is	O
cooperatively	O
stimulated	O
when	O
the	O
distinct	O
LT-betaR	B-protein
and	O
TNF	B-protein
receptor	I-protein
systems	I-protein
are	O
simultaneously	O
engaged	O
by	O
their	O
specific	O
ligands	O
.	O

Moreover	O
,	O
in	O
a	O
physiological	O
coculture	O
cellular	O
assay	O
system	O
,	O
we	O
show	O
that	O
membrane-bound	B-protein
TNF-alpha	I-protein
and	O
LT-alpha1beta2	B-protein
act	O
virtually	O
identically	O
to	O
their	O
soluble	O
forms	O
in	O
the	O
regulation	O
of	O
HIV-1	O
replication	O
.	O

Thus	O
,	O
cosignaling	O
via	O
the	O
LT-beta	B-protein
and	I-protein
TNF-alpha	I-protein
receptors	I-protein
is	O
probably	O
involved	O
in	O
the	O
modulation	O
of	O
HIV-1	O
replication	O
and	O
the	O
subsequent	O
determination	O
of	O
HIV-1	O
viral	O
burden	O
in	O
monocytes	B-cell_type
.	O

Intriguingly	O
,	O
surface	O
expression	O
of	O
LT-alpha1beta2	B-protein
is	O
up-regulated	O
on	O
a	O
T	B-cell_line
cell	I-cell_line
line	I-cell_line
acutely	O
infected	O
with	O
HIV-1	O
,	O
suggesting	O
a	O
positive	O
feedback	O
loop	O
between	O
HIV-1	O
infection	O
,	O
LT-alpha1beta2	B-protein
expression	O
,	O
and	O
HIV-1	O
replication	O
.	O

Given	O
the	O
critical	O
role	O
that	O
LT-alpha1beta2	B-protein
plays	O
in	O
lymphoid	O
architecture	O
,	O
we	O
speculate	O
that	O
LT-alpha1beta2	B-protein
may	O
be	O
involved	O
in	O
HIV-associated	O
abnormalities	O
of	O
the	O
lymphoid	O
organs	O
.	O

3	NULL
<	NULL
.	NULL

a	NULL
el	NULL
(	NULL
ap	NULL
)	NULL
D	NULL
3	NULL
Reporter	NULL
Cell	NULL
Lines	NULL
a	NULL
a	NULL
g	NULL
The	NULL
film	NULL
”	NULL
)	NULL
!	NULL

keeps	NULL
growing	NULL
Learn	NULL
more	NULL
#	NULL
m	NULL
meJournal	NULL
of	NULL
Signaling	NULL
Through	NULL
the	NULL
Lymphotoxin-B	NULL
ﬁa	NULL
’	NULL
lmmunolo	NULL
gy	NULL
Receptor	NULL
Stimulates	NULL
HIV	NULL
Replication	NULL
Alone	NULL
and	NULL
in	NULL
Cooperation	NULL
with	NULL
Soluble	NULL
or	NULL
Membrane-Bound	NULL
TNF	NULL
This	NULL
information	NULL
is	NULL
current	NULL
as	NULL
of	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

William	NULL
L.	NULL
Marshall	NULL
,	NULL
Brigitta	NULL
M.	NULL
N.	NULL
Brinkman	NULL
,	NULL
Christine	NULL
M.	NULL
Ambrose	NULL
,	NULL
Patricia	NULL
A.	NULL
Pesavento	NULL
,	NULL
Adele	NULL
M.	NULL
Uglialoro	NULL
,	NULL
Edna	NULL
Teng	NULL
,	NULL
Robert	NULL
W.	NULL
Finberg	NULL
,	NULL
Jeffrey	NULL
L.	NULL
Browning	NULL
and	NULL
Anne	NULL
E.	NULL
Goldfeld	NULL
J	NULL
Immunol	NULL
1999	NULL
;	NULL
162:6016-6023	NULL
;	NULL
;	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/162/10/6016	NULL
References	NULL
_	NULL
This	NULL
article	NULL
cites	NULL
64	NULL
articles	NULL
,	NULL
30	NULL
of	NULL
which	NULL
you	NULL
can	NULL
access	NULL
for	NULL
free	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/162/10/6016.full	NULL
#	NULL
ref-list-1	NULL
Why	NULL
The	NULL
JT	NULL
?	NULL

Submit	NULL
online	NULL
.	NULL

«	NULL
Rapid	NULL
Reviews	NULL
!	NULL

30	NULL
days*	NULL
from	NULL
submission	NULL
to	NULL
initial	NULL
decision	NULL
*	NULL
No	NULL
Triage	NULL
!	NULL

Every	NULL
submission	NULL
reviewed	NULL
by	NULL
practicing	NULL
scientists	NULL
*	NULL
Fast	NULL
Publication	NULL
!	NULL

4	NULL
weeks	NULL
from	NULL
acceptance	NULL
to	NULL
publication	NULL
*average	NULL
Subscription	NULL
_-	NULL
Information	NULL
about	NULL
subscribing	NULL
to	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/subscription	NULL
Permissions	NULL
_	NULL
Submit	NULL
copyright	NULL
permission	NULL
requests	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.aai.org/About/Publications/Jl/copyright.html	NULL
Email	NULL
Alerts	NULL
_	NULL
Receive	NULL
free	NULL
email-alerts	NULL
when	NULL
new	NULL
articles	NULL
cite	NULL
this	NULL
article	NULL
.	NULL

Sign	NULL
up	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/alerts	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
published	NULL
twice	NULL
each	NULL
month	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
,	NULL
Inc.	NULL
,	NULL
1451	NULL
Rockville	NULL
Pike	NULL
,	NULL
Suite	NULL
650	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
20852	NULL
Copyright	NULL
©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
All	NULL
rights	NULL
reserved	NULL
.	NULL

Print	NULL
ISSN	NULL
:	NULL
0022-1767	NULL
Online	NULL
ISSN	NULL
:	NULL
1550-6606	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
Signaling	NULL
Through	NULL
the	NULL
Lymphotoxin-B	NULL
Receptor	NULL
Stimulates	NULL
HIV-1	NULL
Replication	NULL
Alone	NULL
and	NULL
in	NULL
Cooperation	NULL
with	NULL
Soluble	NULL
or	NULL
Membrane-Bound	NULL
TNF-a	NULL
William	NULL
L.	NULL
Marshall	NULL
,	NULL
``	NULL
Brigitta	NULL
M.	NULL
N.	NULL
Brinkman	NULL
,	NULL
*	NULL
Christine	NULL
M.	NULL
Ambrose	NULL
,	NULL
*	NULL
Patricia	NULL
A.	NULL
Pesavento	NULL
,	NULL
*	NULL
Adele	NULL
M.	NULL
Uglialoro	NULL
,	NULL
*	NULL
Edna	NULL
Teng	NULL
,	NULL
``	NULL
Robert	NULL
W.	NULL
Finberg	NULL
,	NULL
``	NULL
Jeffrey	NULL
L.	NULL
Browning	NULL
,	NULL
``	NULL
and	NULL
Anne	NULL
E.	NULL
Goldfeld®*	NULL
The	NULL
level	NULL
of	NULL
ongoing	NULL
HIV-1	NULL
replication	NULL
within	NULL
an	NULL
individual	NULL
is	NULL
critical	NULL
to	NULL
HIV-1	NULL
pathogenesis	NULL
.	NULL

Among	NULL
host	NULL
immune	NULL
factors	NULL
,	NULL
the	NULL
cytokine	NULL
TNF-a	NULL
has	NULL
previously	NULL
been	NULL
shown	NULL
to	NULL
increase	NULL
HIV-1	NULL
replication	NULL
in	NULL
various	NULL
monocyte	NULL
and	NULL
T	NULL
cell	NULL
model	NULL
systems	NULL
.	NULL

Here	NULL
,	NULL
we	NULL
demonstrate	NULL
that	NULL
signaling	NULL
through	NULL
the	NULL
TNF	NULL
receptor	NULL
family	NULL
member	NULL
,	NULL
the	NULL
lymphotoxin-3	NULL
(	NULL
LT-	NULL
$	NULL
)	NULL
receptor	NULL
(	NULL
LT-BR	NULL
)	NULL
,	NULL
also	NULL
regulates	NULL
HIV-1	NULL
replication	NULL
.	NULL

Furthermore	NULL
,	NULL
HIV	NULL
-1	NULL
replication	NULL
is	NULL
cooperatively	NULL
stimulated	NULL
when	NULL
the	NULL
distinct	NULL
LT-BR	NULL
and	NULL
TNF	NULL
receptor	NULL
systems	NULL
are	NULL
simultaneously	NULL
engaged	NULL
by	NULL
their	NULL
specific	NULL
ligands	NULL
.	NULL

Moreover	NULL
,	NULL
in	NULL
a	NULL
physiological	NULL
coculture	NULL
cellular	NULL
assay	NULL
system	NULL
,	NULL
we	NULL
show	NULL
that	NULL
membrane-bound	NULL
TNF-a	NULL
and	NULL
LT-	NULL
«	NULL
,	NULL
3	NULL
,	NULL
act	NULL
virtually	NULL
identically	NULL
to	NULL
their	NULL
soluble	NULL
forms	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
HIV-1	NULL
replication	NULL
.	NULL

Thus	NULL
,	NULL
cosignaling	NULL
via	NULL
the	NULL
LT-B	NULL
and	NULL
TNF-a	NULL
receptors	NULL
is	NULL
probably	NULL
involved	NULL
in	NULL
the	NULL
modulation	NULL
of	NULL
HIV-1	NULL
replication	NULL
and	NULL
the	NULL
subsequent	NULL
determination	NULL
of	NULL
HIV-1	NULL
viral	NULL
burden	NULL
in	NULL
monocytes	NULL
.	NULL

Intriguingly	NULL
,	NULL
surface	NULL
expression	NULL
of	NULL
LT-a	NULL
&	NULL
,	NULL
,	NULL
is	NULL
up-regulated	NULL
on	NULL
a	NULL
T	NULL
cell	NULL
line	NULL
acutely	NULL
infected	NULL
with	NULL
HIV-1	NULL
,	NULL
suggesting	NULL
a	NULL
positive	NULL
feedback	NULL
loop	NULL
between	NULL
HIV-1	NULL
infection	NULL
,	NULL
LT-	NULL
«	NULL
,	NULL
3	NULL
,	NULL
expression	NULL
,	NULL
and	NULL
HIV-1	NULL
replication	NULL
.	NULL

Given	NULL
the	NULL
critical	NULL
role	NULL
that	NULL
LT-	NULL
«	NULL
,	NULL
f	NULL
;	NULL
,	NULL
plays	NULL
in	NULL
lymphoid	NULL
architecture	NULL
,	NULL
we	NULL
speculate	NULL
that	NULL
LT-	NULL
«	NULL
,	NULL
f	NULL
,	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
HIV-associated	NULL
abnormalities	NULL
of	NULL
the	NULL
lymphoid	NULL
organs	NULL
.	NULL

The	NULL
Journal	NULL
of	NULL
Immunology	NULL
,	NULL
1999	NULL
,	NULL
162	NULL
;	NULL
6016-6023.	NULL
key	NULL
factor	NULL
both	NULL
in	NULL
the	NULL
progression	NULL
of	NULL
HIV-1	NULL
infection	NULL
to	NULL
clinical	NULL
AIDS	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
,	NULL
and	NULL
in	NULL
the	NULL
perinatal	NULL
transmission	NULL
of	NULL
HIV-1	NULL
from	NULL
mother	NULL
to	NULL
fetus	NULL
(	NULL
3-5	NULL
)	NULL
.	NULL

The	NULL
viral	NULL
set-point	NULL
within	NULL
an	NULL
individual	NULL
is	NULL
a	NULL
function	NULL
of	NULL
both	NULL
viral	NULL
elimination	NULL
by	NULL
the	NULL
host	NULL
immune	NULL
system	NULL
and	NULL
the	NULL
ongoing	NULL
level	NULL
of	NULL
HIV-1	NULL
replication	NULL
(	NULL
6	NULL
)	NULL
.	NULL

Although	NULL
host	NULL
immune	NULL
factors	NULL
are	NULL
involved	NULL
in	NULL
both	NULL
these	NULL
processes	NULL
,	NULL
to	NULL
date	NULL
they	NULL
remain	NULL
poorly	NULL
defined	NULL
,	NULL
particularly	NULL
with	NULL
regard	NULL
to	NULL
those	NULL
factors	NULL
that	NULL
regulate	NULL
HIV-1	NULL
replication	NULL
and	NULL
thus	NULL
viral	NULL
load	NULL
(	NULL
reviewed	NULL
in	NULL
Ref	NULL
.	NULL

7	NULL
)	NULL
.	NULL

Among	NULL
host	NULL
immune	NULL
factors	NULL
,	NULL
the	NULL
cytokine	NULL
TNF-	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
increase	NULL
HIV-1	NULL
replication	NULL
in	NULL
various	NULL
monocyte	NULL
and	NULL
T	NULL
cell	NULL
model	NULL
systems	NULL
(	NULL
8	NULL
,	NULL
9	NULL
)	NULL
.	NULL

TNF-a	NULL
@	NULL
exists	NULL
as	NULL
both	NULL
a	NULL
membrane-bound	NULL
26-kDa	NULL
form	NULL
and	NULL
a	NULL
17-kDa	NULL
soluble	NULL
form	NULL
(	NULL
10	NULL
)	NULL
and	NULL
signals	NULL
through	NULL
two	NULL
receptors	NULL
,	NULL
p55	NULL
and	NULL
p75	NULL
(	NULL
reviewed	NULL
in	NULL
Ref	NULL
.	NULL

11	NULL
)	NULL
.	NULL

The	NULL
two	NULL
TNF	NULL
receptors	NULL
induce	NULL
both	NULL
specific	NULL
and	NULL
overlapping	NULL
responses	NULL
,	NULL
including	NULL
activation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
12-15	NULL
)	NULL
.	NULL

It	NULL
has	NULL
been	NULL
suggested	NULL
that	NULL
the	NULL
soluble	NULL
and	NULL
membrane	NULL
forms	NULL
of	NULL
TNF-a	NULL
signal	NULL
preferentially	NULL
through	NULL
p55	NULL
and	NULL
p75	NULL
(	NULL
16	NULL
)	NULL
.	NULL

T	NULL
he	NULL
HIV-1	NULL
viral	NULL
burden	NULL
within	NULL
an	NULL
infected	NULL
individual	NULL
is	NULL
a	NULL
*Center	NULL
for	NULL
Blood	NULL
Research	NULL
and	NULL
*Division	NULL
of	NULL
Adult	NULL
Oncology	NULL
,	NULL
Dana-Farber	NULL
Cancer	NULL
Institute	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
02115	NULL
;	NULL
and	NULL
tBicvgeu	NULL
,	NULL
Inc.	NULL
,	NULL
Cambridge	NULL
,	NULL
MA	NULL
02138	NULL
Received	NULL
for	NULL
publication	NULL
June	NULL
26	NULL
,	NULL
1998	NULL
.	NULL

Accepted	NULL
for	NULL
publication	NULL
February	NULL
26	NULL
,	NULL
1999	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
adverfisement	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL
'	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Grants	NULL
CA58735	NULL
and	NULL
P30CAOGS16-33	NULL
(	NULL
to	NULL
A.E.G	NULL
.	NULL
)	NULL

,	NULL
AI28691-06	NULL
(	NULL
to	NULL
R.W.F	NULL
.	NULL
)	NULL

,	NULL
and	NULL
AIO1078-03	NULL
(	NULL
to	NULL
W.L.M	NULL
.	NULL
)	NULL

;	NULL
an	NULL
Established	NULL
Investigator	NULL
Award	NULL
from	NULL
the	NULL
American	NULL
Heart	NULL
Association	NULL
Foundation	NULL
(	NULL
to	NULL
A.E.G	NULL
.	NULL
)	NULL

;	NULL
and	NULL
a	NULL
grant	NULL
from	NULL
the	NULL
Stichting	NULL
Dr.	NULL
Catharina	NULL
Van	NULL
Tussenbrock	NULL
(	NULL
to	NULL
B.M.N.B	NULL
.	NULL
)	NULL

.	NULL

?	NULL

Address	NULL
correspondence	NULL
and	NULL
reprint	NULL
requests	NULL
to	NULL
Dr.	NULL
Anne	NULL
E.	NULL
Goldfeld	NULL
,	NULL
Center	NULL
for	NULL
Blood	NULL
Research	NULL
,	NULL
800	NULL
Huntington	NULL
Ave.	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
02115	NULL
.	NULL

E-mail	NULL
address	NULL
:	NULL
goldfeld	NULL
@	NULL
cbr.med.harvard.edu	NULL
Copyright	NULL
©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
The	NULL
membrane-anchored	NULL
lymphotoxin-a	NULL
,	NULL
3	NULL
;	NULL
ligand	NULL
molecule	NULL
,	NULL
which	NULL
is	NULL
expressed	NULL
on	NULL
the	NULL
surface	NULL
of	NULL
activated	NULL
T	NULL
and	NULL
B	NULL
cells	NULL
(	NULL
17	NULL
,	NULL
18	NULL
)	NULL
,	NULL
but	NULL
not	NULL
on	NULL
the	NULL
surface	NULL
of	NULL
cells	NULL
of	NULL
nonlymphoid	NULL
or-igin	NULL
,	NULL
binds	NULL
to	NULL
the	NULL
LT-BR	NULL
.	NULL

The	NULL
LT-BR	NULL
is	NULL
expressed	NULL
on	NULL
the	NULL
surface	NULL
of	NULL
some	NULL
monocytic	NULL
cells	NULL
(	NULL
18	NULL
,	NULL
19	NULL
)	NULL
,	NULL
some	NULL
dendritic	NULL
cells	NULL
(	NULL
20	NULL
)	NULL
,	NULL
and	NULL
the	NULL
promyelocyctic	NULL
U937	NULL
cell	NULL
line	NULL
(	NULL
18	NULL
)	NULL
(	NULL
our	NULL
unpublished	NULL
observa-tions	NULL
)	NULL
,	NULL
but	NULL
not	NULL
on	NULL
T	NULL
or	NULL
B	NULL
cells	NULL
.	NULL

The	NULL
LT-BR	NULL
signals	NULL
through	NULL
a	NULL
pathway	NULL
that	NULL
is	NULL
distinct	NULL
from	NULL
the	NULL
TNF	NULL
receptor	NULL
signaling	NULL
pathways	NULL
(	NULL
reviewed	NULL
in	NULL
Ref	NULL
.	NULL

21	NULL
)	NULL
and	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
development	NULL
of	NULL
lymph	NULL
nodes	NULL
,	NULL
the	NULL
maintenance	NULL
of	NULL
lymphoid	NULL
architecture	NULL
,	NULL
and	NULL
the	NULL
function	NULL
of	NULL
follicular	NULL
dendritic	NULL
cells	NULL
(	NULL
18	NULL
,	NULL
21	NULL
,	NULL
22	NULL
)	NULL
.	NULL

An	NULL
additional	NULL
ligand	NULL
of	NULL
unknown	NULL
biological	NULL
function	NULL
called	NULL
LIGHT	NULL
can	NULL
also	NULL
bind	NULL
the	NULL
LT-BR	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Multiple	NULL
studies	NULL
have	NULL
also	NULL
underscored	NULL
the	NULL
importance	NULL
of	NULL
TNF-a	NULL
in	NULL
lymphoid	NULL
biology	NULL
.	NULL

Mice	NULL
deficient	NULL
in	NULL
TNF-a	NULL
lack	NULL
germinal	NULL
center	NULL
formation	NULL
in	NULL
splenic	NULL
follicles	NULL
(	NULL
24-26	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
TNF-a	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
generation	NULL
of	NULL
follicular	NULL
dendritic	NULL
cells	NULL
(	NULL
27	NULL
)	NULL
and	NULL
B	NULL
cell	NULL
proliferation	NULL
(	NULL
28	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
given	NULL
that	NULL
disruption	NULL
of	NULL
lymphoid	NULL
architecture	NULL
is	NULL
a	NULL
hallmark	NULL
of	NULL
HIV-1	NULL
infection	NULL
(	NULL
29	NULL
,	NULL
30	NULL
)	NULL
,	NULL
LT-a	NULL
,	NULL
B	NULL
,	NULL
and	NULL
TNF-a	NULL
@	NULL
are	NULL
particularly	NULL
interesting	NULL
candidate	NULL
host	NULL
factors	NULL
to	NULL
study	NULL
in	NULL
relation	NULL
to	NULL
HIV-1	NULL
disease	NULL
progression	NULL
and	NULL
pathogenesis	NULL
.	NULL

The	NULL
monocyte	NULL
plays	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
the	NULL
progression	NULL
of	NULL
HIV-1	NULL
infection	NULL
.	NULL

HIV-1-infected	NULL
monocytes	NULL
are	NULL
numerous	NULL
early	NULL
in	NULL
HIV-1	NULL
infection	NULL
and	NULL
are	NULL
a	NULL
major	NULL
source	NULL
of	NULL
virus	NULL
in	NULL
advanced	NULL
AIDS	NULL
when	NULL
the	NULL
T	NULL
cell	NULL
population	NULL
has	NULL
been	NULL
depleted	NULL
(	NULL
30-32	NULL
)	NULL
.	NULL

The	NULL
host	NULL
factors	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
HIV-1	NULL
replication	NULL
in	NULL
monocytes	NULL
are	NULL
therefore	NULL
of	NULL
particular	NULL
importance	NULL
in	NULL
the	NULL
establishment	NULL
of	NULL
HIV-1	NULL
infection	NULL
,	NULL
viral	NULL
burden	NULL
,	NULL
and	NULL
disease	NULL
progression	NULL
.	NULL

3	NULL
Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
LT-a	NULL
,	NULL
f	NULL
;	NULL
,	NULL
,	NULL
lymphotoxin-a	NULL
,	NULL
f	NULL
,	NULL
;	NULL
LT-BR	NULL
,	NULL
lympho-toxin-	NULL
receptor	NULL
;	NULL
LT-	NULL
@	NULL
s	NULL
,	NULL
lymphotoxin-	NULL
«	NULL
@	NULL
homotrimer	NULL
;	NULL
wt-TNF	NULL
,	NULL
wild-type	NULL
TNF	NULL
;	NULL
mTNF	NULL
,	NULL
membrane-bound	NULL
TNF	NULL
;	NULL
TRAF	NULL
,	NULL
TNF	NULL
receptor-associated	NULL
factor	NULL
.	NULL

0022-1767/99/	NULL
$	NULL
02.00	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
To	NULL
explore	NULL
the	NULL
role	NULL
of	NULL
TNF-a	NULL
and	NULL
LT-a	NULL
,	NULL
3	NULL
,	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
HIV-1	NULL
in	NULL
infected	NULL
monocytes	NULL
,	NULL
we	NULL
used	NULL
the	NULL
chronically	NULL
HIV-1-infected	NULL
U1	NULL
cell	NULL
line	NULL
,	NULL
which	NULL
is	NULL
the	NULL
best	NULL
characterized	NULL
reproducible	NULL
in	NULL
vitro	NULL
monocytic	NULL
system	NULL
used	NULL
to	NULL
study	NULL
cytokine-mediated	NULL
HIV-1	NULL
replication	NULL
(	NULL
9	NULL
,	NULL
33	NULL
,	NULL
34	NULL
)	NULL
.	NULL

Here	NULL
,	NULL
we	NULL
show	NULL
that	NULL
costimulation	NULL
through	NULL
LT-BR	NULL
and	NULL
TNF	NULL
receptors	NULL
results	NULL
in	NULL
a	NULL
dramatic	NULL
increase	NULL
in	NULL
viral	NULL
replication	NULL
in	NULL
U1	NULL
cells	NULL
.	NULL

Furthermore	NULL
,	NULL
cocultivation	NULL
of	NULL
cells	NULL
expressing	NULL
membrane-bound	NULL
forms	NULL
of	NULL
LT-	NULL
«	NULL
,	NULL
3	NULL
;	NULL
and	NULL
TNF-a	NULL
with	NULL
U1	NULL
cells	NULL
or	NULL
the	NULL
clustering	NULL
of	NULL
the	NULL
LT-BR	NULL
and	NULL
TNFp75	NULL
receptors	NULL
on	NULL
U1	NULL
cells	NULL
also	NULL
greatly	NULL
increases	NULL
viral	NULL
replication	NULL
.	NULL

These	NULL
studies	NULL
thus	NULL
indicate	NULL
that	NULL
signaling	NULL
through	NULL
the	NULL
LT-B	NULL
and	NULL
TNF	NULL
receptors	NULL
in	NULL
monocytes	NULL
may	NULL
influence	NULL
HIV-1	NULL
viral	NULL
burden	NULL
and	NULL
disease	NULL
progression	NULL
.	NULL

Furthermore	NULL
,	NULL
they	NULL
suggest	NULL
that	NULL
strategies	NULL
that	NULL
inhibit	NULL
TNF-a	NULL
and	NULL
LT-a	NULL
,	NULL
3	NULL
,	NULL
expression	NULL
and	NULL
signaling	NULL
may	NULL
be	NULL
useful	NULL
in	NULL
decreasing	NULL
HIV-1	NULL
viral	NULL
burden	NULL
and	NULL
thus	NULL
disease	NULL
progression	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Cell	NULL
culture	NULL
The	NULL
following	NULL
reagents	NULL
were	NULL
obtained	NULL
from	NULL
the	NULL
AIDS	NULL
Reference	NULL
Reagents	NULL
Program	NULL
:	NULL
CEM	NULL
,	NULL
Jurkat	NULL
,	NULL
and	NULL
H9	NULL
cell	NULL
lines	NULL
.	NULL

The	NULL
II-23	NULL
cell	NULL
line	NULL
was	NULL
previously	NULL
described	NULL
(	NULL
14	NULL
)	NULL
.	NULL

The	NULL
U1	NULL
cell	NULL
line	NULL
(	NULL
34	NULL
)	NULL
undergoes	NULL
a	NULL
time-dependent	NULL
decay	NULL
in	NULL
the	NULL
ability	NULL
of	NULL
TNF-a	NULL
to	NULL
induce	NULL
HIV-1	NULL
replication	NULL
as	NULL
noted	NULL
previously	NULL
(	NULL
33	NULL
,	NULL
34	NULL
)	NULL
.	NULL

We	NULL
obtained	NULL
U1	NULL
cells	NULL
from	NULL
the	NULL
AIDS	NULL
Repository	NULL
,	NULL
and	NULL
U1	NULL
clones	NULL
were	NULL
isolated	NULL
by	NULL
limiting	NULL
dilution	NULL
and	NULL
then	NULL
selected	NULL
for	NULL
maximal	NULL
responsiveness	NULL
to	NULL
TNF-a	NULL
.	NULL

More	NULL
than	NULL
one	NULL
clone	NULL
was	NULL
used	NULL
in	NULL
the	NULL
experiments	NULL
described	NULL
with	NULL
the	NULL
U1	NULL
cell	NULL
line	NULL
,	NULL
and	NULL
results	NULL
were	NULL
comparable	NULL
between	NULL
clones	NULL
.	NULL

Cells	NULL
were	NULL
maintained	NULL
in	NULL
RPMI	NULL
1640	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
FBS	NULL
with	NULL
L-glutamine	NULL
and	NULL
penicillin/streptomycin	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Gaithersburg	NULL
,	NULL
MD	NULL
)	NULL
.	NULL

H9	NULL
cells	NULL
were	NULL
infected	NULL
with	NULL
the	NULL
HIV-lyy	NULL
strain	NULL
at	NULL
a	NULL
multiplicity	NULL
of	NULL
infection	NULL
of	NULL
1.0	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
35	NULL
,	NULL
36	NULL
)	NULL
and	NULL
were	NULL
analyzed	NULL
by	NULL
flow	NULL
cytometry	NULL
for	NULL
expression	NULL
of	NULL
surface	NULL
LT-a	NULL
,	NULL
B	NULL
;	NULL
,	NULL
or	NULL
TNF-	NULL
«	NULL
.	NULL

Cells	NULL
were	NULL
preincubated	NULL
with	NULL
human	NULL
serum	NULL
for	NULL
20	NULL
min	NULL
at	NULL
4°C	NULL
,	NULL
and	NULL
all	NULL
subsequent	NULL
incuba-tions	NULL
were	NULL
performed	NULL
at	NULL
4°C	NULL
for	NULL
40	NULL
min	NULL
each	NULL
.	NULL

Cells	NULL
were	NULL
incubated	NULL
with	NULL
LT-BR-Fc	NULL
or	NULL
with	NULL
the	NULL
anti-TNF-a	NULL
«	NULL
Ab	NULL
cAZ	NULL
(	NULL
see	NULL
Reagents	NULL
below	NULL
)	NULL
.	NULL

As	NULL
a	NULL
negative	NULL
control	NULL
,	NULL
some	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
human	NULL
IgG1	NULL
.	NULL

This	NULL
was	NULL
followed	NULL
by	NULL
incubation	NULL
with	NULL
FITC-labeled	NULL
goat	NULL
anti-human	NULL
(	NULL
F	NULL
(	NULL
ab	NULL
'	NULL
)	NULL
,	NULL
(	NULL
Bio-Source	NULL
,	NULL
Camarillo	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
Abs	NULL
NC2	NULL
and	NULL
CH12	NULL
(	NULL
see	NULL
Reagents	NULL
below	NULL
)	NULL
were	NULL
used	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
37	NULL
)	NULL
.	NULL

The	NULL
human	NULL
embryonic	NULL
kidney	NULL
cell	NULL
line	NULL
E293	NULL
,	NULL
stably	NULL
transfected	NULL
with	NULL
EBV	NULL
nuclear	NULL
Ag	NULL
,	NULL
was	NULL
obtained	NULL
from	NULL
Invitrogen	NULL
(	NULL
Carlsbad	NULL
,	NULL
CA	NULL
)	NULL
and	NULL
maintained	NULL
in	NULL
DMEM	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
FBS	NULL
,	NULL
L-glutamine	NULL
,	NULL
penicillin/	NULL
streptomycin	NULL
(	NULL
Life	NULL
Technologies	NULL
)	NULL
,	NULL
and	NULL
250	NULL
pg/ml	NULL
G418	NULL
.	NULL

The	NULL
p24	NULL
concentration	NULL
was	NULL
determined	NULL
by	NULL
ELISA	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
specifications	NULL
(	NULL
New	NULL
England	NULL
Nuclear-DuPont	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

Reagents	NULL
The	NULL
properties	NULL
of	NULL
the	NULL
recombinant	NULL
LT-a	NULL
,	NULL
B	NULL
;	NULL
,	NULL
ligand	NULL
have	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
38	NULL
)	NULL
.	NULL

The	NULL
anti-LT-BR	NULL
Ab	NULL
,	NULL
CBE-11	NULL
(	NULL
39	NULL
)	NULL
;	NULL
the	NULL
anti-TNF-R75	NULL
Ab	NULL
(	NULL
a	NULL
gift	NULL
from	NULL
W.	NULL
Lesslauer	NULL
,	NULL
Hoffmann-La	NULL
Roche	NULL
,	NULL
Basel	NULL
,	NULL
Switzerland	NULL
)	NULL
(	NULL
40	NULL
)	NULL
;	NULL
and	NULL
the	NULL
anti-very	NULL
late	NULL
Ag-2	NULL
Ab	NULL
,	NULL
DEY	NULL
(	NULL
a	NULL
gift	NULL
from	NULL
J.	NULL
Bergelson	NULL
)	NULL
(	NULL
41	NULL
)	NULL
have	NULL
all	NULL
been	NULL
previously	NULL
described	NULL
.	NULL

The	NULL
Abs	NULL
NC2	NULL
and	NULL
CH12	NULL
,	NULL
which	NULL
respectively	NULL
recognized	NULL
either	NULL
all	NULL
LT-o-containing	NULL
forms	NULL
or	NULL
only	NULL
LT-	NULL
«	NULL
,	NULL
B	NULL
,	NULL
forms	NULL
of	NULL
surface	NULL
LT	NULL
,	NULL
have	NULL
also	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
37	NULL
)	NULL
.	NULL

The	NULL
control	NULL
Abs	NULL
MOPC	NULL
21	NULL
(	NULL
a	NULL
murine	NULL
IgG1	NULL
)	NULL
and	NULL
human	NULL
IgG1	NULL
were	NULL
obtained	NULL
from	NULL
Sigma	NULL
(	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
.	NULL

Recombinant	NULL
TNF-a	NULL
was	NULL
purchased	NULL
from	NULL
Genzyme	NULL
(	NULL
Cam-bridge	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

The	NULL
anti-TNF-	NULL
«	NULL
Ab	NULL
,	NULL
cA2	NULL
,	NULL
and	NULL
the	NULL
isotype-matched	NULL
control	NULL
Ab	NULL
were	NULL
gifts	NULL
from	NULL
Centocor	NULL
(	NULL
Malverne	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
LT-BR-Fc	NULL
and	NULL
TNF-R55-Fc	NULL
fusion	NULL
proteins	NULL
have	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
37	NULL
)	NULL
.	NULL

Receptor-Fc	NULL
fusion	NULL
proteins	NULL
can	NULL
lead	NULL
to	NULL
FcR	NULL
binding	NULL
,	NULL
which	NULL
can	NULL
,	NULL
in	NULL
turn	NULL
,	NULL
stimulate	NULL
monocytes	NULL
to	NULL
produce	NULL
HIV-1	NULL
(	NULL
42	NULL
)	NULL
,	NULL
thereby	NULL
complicating	NULL
the	NULL
analysis	NULL
of	NULL
inhibition	NULL
by	NULL
the	NULL
fusion	NULL
proteins	NULL
.	NULL

To	NULL
ensure	NULL
that	NULL
Fc	NULL
receptor-mediated	NULL
events	NULL
did	NULL
not	NULL
complicate	NULL
the	NULL
analysis	NULL
of	NULL
spec-ificity	NULL
,	NULL
in	NULL
some	NULL
experiments	NULL
an	NULL
LT-BR-Fc	NULL
construct	NULL
lacking	NULL
the	NULL
CH2	NULL
domain	NULL
was	NULL
employed	NULL
as	NULL
a	NULL
control	NULL
.	NULL

This	NULL
construct	NULL
can	NULL
not	NULL
bind	NULL
Fc	NULL
receptors	NULL
or	NULL
fix	NULL
complement	NULL
,	NULL
and	NULL
its	NULL
origin	NULL
has	NULL
been	NULL
previously	NULL
described	NULL
(	NULL
37	NULL
)	NULL
.	NULL

CHO	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
resulting	NULL
construct	NULL
,	NULL
and	NULL
purified	NULL
CH2-less	NULL
LT-BR-Fc	NULL
was	NULL
purified	NULL
from	NULL
the	NULL
CHO	NULL
cell	NULL
supernatants	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
37	NULL
)	NULL
.	NULL

Receptor	NULL
cross-linking	NULL
experiments	NULL
Affinity-purified	NULL
goat	NULL
anti-IgG	NULL
Fc	NULL
(	NULL
Jackson	NULL
ImmunoResearch	NULL
Laboratories	NULL
,	NULL
West	NULL
Grove	NULL
,	NULL
PA	NULL
)	NULL
was	NULL
immobilized	NULL
on	NULL
24-well	NULL
plates	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
39	NULL
,	NULL
43	NULL
)	NULL
and	NULL
was	NULL
incubated	NULL
with	NULL
the	NULL
Abs	NULL
noted	NULL
in	NULL
the	NULL
figures	NULL
.	NULL

U1	NULL
cells	NULL
6017	NULL
were	NULL
plated	NULL
on	NULL
the	NULL
washed	NULL
plates	NULL
at	NULL
2	NULL
X	NULL
10°	NULL
cells/ml	NULL
,	NULL
and	NULL
p24	NULL
values	NULL
were	NULL
measured	NULL
from	NULL
supernatants	NULL
at	NULL
48	NULL
h.	NULL
EMSA	NULL
U1	NULL
cells	NULL
were	NULL
incubated	NULL
for	NULL
2	NULL
h	NULL
with	NULL
or	NULL
without	NULL
100	NULL
U/ml	NULL
TNF-a	NULL
or	NULL
LT-	NULL
«	NULL
,	NULL
B	NULL
,	NULL
at	NULL
50	NULL
ng/ml	NULL
where	NULL
indicated	NULL
,	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
,	NULL
and	NULL
EMSAs	NULL
were	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
44	NULL
)	NULL
.	NULL

The	NULL
synthetic	NULL
oli-gonucleotides	NULL
used	NULL
in	NULL
the	NULL
EMSA	NULL
were	NULL
:	NULL
HIV-1-NF-	NULL
«	NULL
B	NULL
,	NULL
5	NULL
``	NULL
-TCGACCG	NULL
AGTGGGGACTTTCCTCTG-3	NULL
'	NULL
(	NULL
-61	NULL
to	NULL
-27	NULL
nucleotides	NULL
)	NULL
and	NULL
5'-GT	NULL
TGAATGATTCTTTCCCCGCCCTCCTCTCGCCCCAGGGACA-3	NULL
'	NULL
.	NULL

DNA	NULL
constructs	NULL
and	NULL
transfection	NULL
The	NULL
derivation	NULL
of	NULL
the	NULL
vectors	NULL
used	NULL
for	NULL
the	NULL
expression	NULL
of	NULL
LT-	NULL
«	NULL
D50N	NULL
and	NULL
LT-B	NULL
in	NULL
E293	NULL
cells	NULL
has	NULL
been	NULL
described	NULL
(	NULL
45	NULL
)	NULL
.	NULL

The	NULL
wild-type	NULL
human	NULL
TNF-a	NULL
gene	NULL
was	NULL
amplified	NULL
from	NULL
an	NULL
activated	NULL
cDNA	NULL
library	NULL
derived	NULL
from	NULL
I-23	NULL
cells	NULL
using	NULL
PCR	NULL
primers	NULL
designed	NULL
to	NULL
complement	NULL
the	NULL
12	NULL
nucleotides	NULL
or	NULL
the	NULL
last	NULL
12	NULL
nucleotides	NULL
of	NULL
the	NULL
cDNA	NULL
encoding	NULL
TNF-	NULL
@	NULL
.	NULL

The	NULL
mutant	NULL
membrane-retained	NULL
form	NULL
of	NULL
human	NULL
TNF-	NULL
«	NULL
was	NULL
constructed	NULL
from	NULL
a	NULL
genomic	NULL
clone	NULL
containing	NULL
deletion	NULL
of	NULL
the	NULL
first	NULL
12	NULL
TNF-a	NULL
amino	NULL
acids	NULL
(	NULL
TNF	NULL
(	NULL
AL-12	NULL
)	NULL
;	NULL
a	NULL
gift	NULL
from	NULL
G.	NULL
Kollias	NULL
)	NULL
from	NULL
which	NULL
the	NULL
TNF-a	NULL
promoter	NULL
was	NULL
excised	NULL
.	NULL

The	NULL
wild	NULL
type	NULL
TNF-a	NULL
@	NULL
and	NULL
the	NULL
mutant	NULL
TNF	NULL
(	NULL
A1-12	NULL
)	NULL
genes	NULL
were	NULL
then	NULL
subcloned	NULL
into	NULL
the	NULL
CH269	NULL
vector	NULL
and	NULL
verified	NULL
by	NULL
sequencing	NULL
.	NULL

E293	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
CH269	NULL
vector	NULL
alone	NULL
,	NULL
wild-type	NULL
TNF-	NULL
«	NULL
,	NULL
mutant	NULL
membrane-bound	NULL
TNF-	NULL
or	NULL
a	NULL
combination	NULL
of	NULL
the	NULL
LT-e	NULL
(	NULL
D5ON	NULL
)	NULL
,	NULL
B	NULL
,	NULL
and	NULL
LT-	NULL
$	NULL
constructs	NULL
using	NULL
Lipofectamine	NULL
(	NULL
Life	NULL
Technologies	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

Cells	NULL
were	NULL
analyzed	NULL
by	NULL
flow	NULL
cytometry	NULL
for	NULL
surface	NULL
expression	NULL
of	NULL
LT-	NULL
«	NULL
(	NULL
D50N	NULL
)	NULL
,	NULL
B	NULL
,	NULL
and	NULL
membrane-bound	NULL
TNF-	NULL
«	NULL
.	NULL

After	NULL
48	NULL
h	NULL
,	NULL
transfected	NULL
E293	NULL
cells	NULL
were	NULL
cocultured	NULL
with	NULL
U1	NULL
monocytes	NULL
at	NULL
a	NULL
5:1	NULL
E	NULL
:	NULL
T	NULL
cell	NULL
ratio	NULL
for	NULL
75	NULL
h.	NULL
In	NULL
addition	NULL
,	NULL
supernatants	NULL
from	NULL
the	NULL
transfected	NULL
E293	NULL
cells	NULL
were	NULL
used	NULL
to	NULL
culture	NULL
U1	NULL
cells	NULL
for	NULL
72	NULL
h	NULL
,	NULL
and	NULL
then	NULL
U1	NULL
supernatants	NULL
were	NULL
analyzed	NULL
from	NULL
triplicate	NULL
wells	NULL
for	NULL
HIV-1	NULL
p24	NULL
Ag	NULL
production	NULL
by	NULL
ELISA	NULL
.	NULL

To	NULL
ensure	NULL
that	NULL
there	NULL
was	NULL
no	NULL
secreted	NULL
TNF-	NULL
«	NULL
in	NULL
the	NULL
supernatants	NULL
of	NULL
the	NULL
E293	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
mutant	NULL
membrane-bound	NULL
TNF-	NULL
«	NULL
plasmid	NULL
,	NULL
a	NULL
TNF-	NULL
ELISA	NULL
was	NULL
performed	NULL
on	NULL
these	NULL
supernatants	NULL
according	NULL
to	NULL
the	NULL
specifications	NULL
of	NULL
the	NULL
manufacturer	NULL
(	NULL
Endogen	NULL
,	NULL
Woburn	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

The	NULL
LT-BRFc	NULL
(	NULL
2.5	NULL
ug/ml	NULL
)	NULL
,	NULL
anti-TNF-a	NULL
«	NULL
cA2	NULL
Ab	NULL
(	NULL
2.5	NULL
ug/ml	NULL
)	NULL
,	NULL
and	NULL
control	NULL
human	NULL
IgG1	NULL
(	NULL
2.5	NULL
ug/ml	NULL
!	NULL
)	NULL

were	NULL
preincubated	NULL
with	NULL
E293	NULL
cells	NULL
.	NULL

To	NULL
exclude	NULL
the	NULL
presence	NULL
of	NULL
secreted	NULL
or	NULL
shed	NULL
surface	NULL
LT-	NULL
(	NULL
D50N	NULL
)	NULL
,	NULL
B	NULL
,	NULL
ligand	NULL
that	NULL
could	NULL
stimulate	NULL
p24	NULL
expression	NULL
,	NULL
supernatants	NULL
from	NULL
cells	NULL
treated	NULL
as	NULL
described	NULL
above	NULL
were	NULL
assayed	NULL
for	NULL
LT	NULL
cytotoxic	NULL
activity	NULL
using	NULL
a	NULL
HT29	NULL
cytotoxicity	NULL
assay	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
38	NULL
)	NULL
.	NULL

Results	NULL
LT-a	NULL
,	NULL
f	NULL
;	NULL
stimulates	NULL
HIV-1	NULL
replication	NULL
in	NULL
the	NULL
UI	NULL
monocytic	NULL
cell	NULL
line	NULL
To	NULL
test	NULL
whether	NULL
LT-a	NULL
,	NULL
3	NULL
,	NULL
could	NULL
induce	NULL
HIV-1	NULL
replication	NULL
,	NULL
we	NULL
stimulated	NULL
U1	NULL
cells	NULL
with	NULL
soluble	NULL
LT-	NULL
«	NULL
,	NULL
B	NULL
;	NULL
,	NULL
and	NULL
quantified	NULL
p24	NULL
Ag	NULL
levels	NULL
as	NULL
a	NULL
measure	NULL
of	NULL
HIV-1	NULL
replication	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
stimulation	NULL
of	NULL
U1	NULL
cells	NULL
with	NULL
LT-	NULL
«	NULL
,	NULL
B	NULL
;	NULL
,	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
10	NULL
ng/ml	NULL
resulted	NULL
in	NULL
a	NULL
2.8-fold	NULL
increase	NULL
in	NULL
HIV-1	NULL
replication	NULL
.	NULL

We	NULL
note	NULL
that	NULL
concentrations	NULL
of	NULL
LT-a	NULL
,	NULL
B	NULL
,	NULL
between	NULL
10-50	NULL
ng/ml	NULL
are	NULL
in	NULL
the	NULL
linear	NULL
range	NULL
of	NULL
the	NULL
LT-	NULL
«	NULL
,	NULL
3	NULL
,	NULL
dose	NULL
response	NULL
of	NULL
U1	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
a	NULL
kinetic	NULL
analysis	NULL
of	NULL
LT-	NULL
«	NULL
,	NULL
3	NULL
,	NULL
stimulation	NULL
of	NULL
HIV-1	NULL
replication	NULL
demonstrated	NULL
a	NULL
sustained	NULL
increase	NULL
in	NULL
p24	NULL
levels	NULL
in	NULL
LT-	NULL
&	NULL
,	NULL
3	NULL
,	NULL
U1	NULL
cells	NULL
on	NULL
days	NULL
7	NULL
,	NULL
14	NULL
,	NULL
18	NULL
,	NULL
and	NULL
21	NULL
poststimulation	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
TNF-a	NULL
treatment	NULL
(	NULL
1	NULL
ng/m	NULL
!	NULL
)	NULL

of	NULL
the	NULL
cells	NULL
resulted	NULL
in	NULL
peak	NULL
p24	NULL
production	NULL
on	NULL
day	NULL
5	NULL
,	NULL
which	NULL
was	NULL
sustained	NULL
for	NULL
a	NULL
total	NULL
of	NULL
14	NULL
days	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
verify	NULL
that	NULL
stimulation	NULL
of	NULL
HIV-1	NULL
by	NULL
LT-a	NULL
,	NULL
,	NULL
was	NULL
mediated	NULL
specifically	NULL
by	NULL
the	NULL
LT-	NULL
@	NULL
,	NULL
3	NULL
,	NULL
ligand	NULL
and	NULL
not	NULL
by	NULL
LT-a	NULL
;	NULL
,	NULL
a	NULL
potential	NULL
contaminant	NULL
that	NULL
binds	NULL
to	NULL
and	NULL
signals	NULL
through	NULL
the	NULL
two	NULL
TNF	NULL
receptors	NULL
but	NULL
not	NULL
through	NULL
the	NULL
LT-BR	NULL
(	NULL
46	NULL
)	NULL
,	NULL
we	NULL
employed	NULL
a	NULL
LT-BR	NULL
decoy	NULL
module	NULL
.	NULL

The	NULL
LT-BR	NULL
decoy	NULL
molecule	NULL
is	NULL
a	NULL
LT-BR	NULL
Ig	NULL
Fc	NULL
fusion	NULL
protein	NULL
that	NULL
binds	NULL
to	NULL
and	NULL
blocks	NULL
the	NULL
function	NULL
of	NULL
LT-	NULL
@	NULL
,	NULL
f	NULL
;	NULL
,	NULL
,	NULL
but	NULL
not	NULL
LT-a	NULL
,	NULL
(	NULL
46	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
the	NULL
LT-BR	NULL
decoy	NULL
molecule	NULL
blocked	NULL
LT-a	NULL
,	NULL
B	NULL
,	NULL
-mediated	NULL
stimulation	NULL
of	NULL
HIV-1	NULL
replication	NULL
,	NULL
whereas	NULL
a	NULL
mAb	NULL
to	NULL
TNF-a	NULL
did	NULL
not	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
LT-	NULL
«	NULL
,	NULL
3	NULL
,	NULL
effect	NULL
is	NULL
not	NULL
secondary	NULL
to	NULL
stimulation	NULL
of	NULL
the	NULL
TNF	NULL
receptors	NULL
through	NULL
an	NULL
LT-	NULL
«	NULL
;	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
6018	NULL
LT-B	NULL
AND	NULL
TNF-	NULL
«	NULL
STIMULATE	NULL
HIV-1	NULL
REPLICATION	NULL
IN	NULL
U1	NULL
CELLS	NULL
LToiB2	NULL
._	NULL
4	NULL
+	NULL
4	NULL
2000	NULL
15007	NULL
1000-7	NULL
500-7	NULL
I	NULL
Conc	NULL
.	NULL

p24	NULL
Antigen	NULL
pg/ml	NULL
+Anti-	NULL
-	NULL
+LTBR-Fe	NULL
TNF	NULL
FIGURE	NULL
1	NULL
.	NULL

LT-a	NULL
,	NULL
8	NULL
;	NULL
stimulates	NULL
HIV-1	NULL
replication	NULL
in	NULL
the	NULL
U1	NULL
monocytic	NULL
cell	NULL
line	NULL
.	NULL

The	NULL
promyelomonocytic	NULL
cell	NULL
line	NULL
,	NULL
U1	NULL
,	NULL
that	NULL
is	NULL
chronically	NULL
infected	NULL
with	NULL
HIV-1	NULL
,	NULL
was	NULL
grown	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
34	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
treated	NULL
with	NULL
LT-	NULL
«	NULL
,	NULL
B	NULL
,	NULL
(	NULL
38	NULL
)	NULL
at	NULL
10	NULL
ng/ml	NULL
or	NULL
approximately	NULL
100	NULL
pM	NULL
,	NULL
the	NULL
half-maximal	NULL
stimulatory	NULL
concentration	NULL
of	NULL
f	NULL
,	NULL
in	NULL
these	NULL
experiments	NULL
,	NULL
and	NULL
p24	NULL
Ag	NULL
levels	NULL
were	NULL
measured	NULL
48	NULL
h	NULL
later	NULL
.	NULL

The	NULL
anti-TNF-a	NULL
Ab	NULL
cAZ	NULL
at	NULL
5	NULL
pg/ml	NULL
or	NULL
the	NULL
LT-BR-blocking	NULL
Ab	NULL
(	NULL
LT-BRFc-CH2-less	NULL
;	NULL
5	NULL
ug/ml	NULL
)	NULL
was	NULL
added	NULL
to	NULL
the	NULL
cells	NULL
as	NULL
indicated	NULL
.	NULL

There	NULL
was	NULL
no	NULL
difference	NULL
in	NULL
cellular	NULL
viability	NULL
as	NULL
determined	NULL
by	NULL
trypan	NULL
blue	NULL
exclusion	NULL
between	NULL
LT-o	NULL
,	NULL
,	NULL
-treated	NULL
and	NULL
untreated	NULL
U1	NULL
cells	NULL
.	NULL

The	NULL
results	NULL
shown	NULL
are	NULL
consistent	NULL
with	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

The	NULL
error	NULL
bars	NULL
represent	NULL
the	NULL
SD	NULL
between	NULL
duplicate	NULL
values	NULL
in	NULL
the	NULL
experiment	NULL
displayed	NULL
.	NULL

By	NULL
flow	NULL
cytometric	NULL
analysis	NULL
(	NULL
FACS	NULL
)	NULL
we	NULL
demonstrated	NULL
that	NULL
the	NULL
U1	NULL
promyelomonocytic	NULL
cell	NULL
line	NULL
expresses	NULL
the	NULL
LT-BR	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

We	NULL
note	NULL
that	NULL
addition	NULL
of	NULL
LT-o	NULL
,	NULL
3	NULL
;	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
10	NULL
ng/m	NULL
!	NULL

resulted	NULL
in	NULL
an	NULL
average	NULL
3-	NULL
to	NULL
10-fold	NULL
increase	NULL
in	NULL
HIV-1	NULL
replication	NULL
dependent	NULL
upon	NULL
the	NULL
particular	NULL
U1	NULL
clone	NULL
tested	NULL
.	NULL

contaminant	NULL
or	NULL
by	NULL
TNF-a	NULL
itself	NULL
(	NULL
9	NULL
,	NULL
33	NULL
)	NULL
.	NULL

These	NULL
results	NULL
establish	NULL
an	NULL
independent	NULL
pathway	NULL
for	NULL
LT-	NULL
«	NULL
,	NULL
;	NULL
,	NULL
signaling	NULL
of	NULL
HIV-1	NULL
in	NULL
infected	NULL
U1	NULL
cells	NULL
.	NULL

LT-a	NULL
,	NULL
B	NULL
,	NULL
and	NULL
TNF-a	NULL
stimulate	NULL
HIV-1	NULL
replication	NULL
in	NULL
a	NULL
synergistic	NULL
manner	NULL
The	NULL
effect	NULL
of	NULL
adding	NULL
soluble	NULL
TNF-a	NULL
together	NULL
with	NULL
LT-a	NULL
,	NULL
B	NULL
;	NULL
,	NULL
to	NULL
U1	NULL
cells	NULL
was	NULL
up	NULL
to	NULL
10-fold	NULL
greater	NULL
than	NULL
the	NULL
effect	NULL
of	NULL
adding	NULL
either	NULL
cytokine	NULL
alone	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

This	NULL
functional	NULL
cooperation	NULL
can	NULL
be	NULL
blocked	NULL
by	NULL
an	NULL
Ab	NULL
to	NULL
TNF-a	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
or	NULL
by	NULL
TNFR55-Fc	NULL
,	NULL
a	NULL
TNF-	NULL
«	NULL
receptor	NULL
Fc	NULL
decoy	NULL
molecule	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Treatment	NULL
with	NULL
either	NULL
of	NULL
these	NULL
TNF-a	NULL
Abs	NULL
resulted	NULL
in	NULL
a	NULL
decrease	NULL
in	NULL
p24	NULL
production	NULL
to	NULL
the	NULL
level	NULL
expected	NULL
with	NULL
LT-o	NULL
,	NULL
B	NULL
,	NULL
stimulation	NULL
alone	NULL
.	NULL

Similarly	NULL
,	NULL
the	NULL
LTBR-Fc	NULL
decoy	NULL
molecule	NULL
blocked	NULL
the	NULL
cooperative	NULL
effect	NULL
of	NULL
LT-a	NULL
,	NULL
B	NULL
,	NULL
and	NULL
TNF-	NULL
«	NULL
to	NULL
the	NULL
level	NULL
of	NULL
p24	NULL
production	NULL
expected	NULL
in	NULL
U1	NULL
cells	NULL
stimulated	NULL
by	NULL
TNF-a	NULL
alone	NULL
.	NULL

Stimulation	NULL
of	NULL
HIV-1	NULL
replication	NULL
by	NULL
the	NULL
combination	NULL
of	NULL
TNF-a	NULL
@	NULL
and	NULL
LT-	NULL
«	NULL
,	NULL
3	NULL
,	NULL
could	NULL
be	NULL
completely	NULL
abrogated	NULL
by	NULL
treating	NULL
the	NULL
cells	NULL
with	NULL
a	NULL
combination	NULL
of	NULL
the	NULL
LT-BR-Fc	NULL
and	NULL
TNFR-Fc	NULL
decoy	NULL
molecules	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
LT-	NULL
@	NULL
,	NULL
B	NULL
,	NULL
and	NULL
TNF-a	NULL
act	NULL
cooperatively	NULL
to	NULL
stimulate	NULL
HIV-1	NULL
replication	NULL
.	NULL

Surface	NULL
,	NULL
f	NULL
,	NULL
and	NULL
TNF-a	NULL
stimulate	NULL
HIV-1	NULL
replication	NULL
in	NULL
UI	NULL
cells	NULL
Since	NULL
the	NULL
functional	NULL
form	NULL
of	NULL
LT-a	NULL
,	NULL
$	NULL
3	NULL
;	NULL
is	NULL
membrane	NULL
anchored	NULL
(	NULL
14	NULL
,	NULL
37	NULL
,	NULL
47	NULL
)	NULL
,	NULL
and	NULL
TNF-a	NULL
occurs	NULL
in	NULL
both	NULL
a	NULL
membrane-bound	NULL
and	NULL
a	NULL
soluble	NULL
form	NULL
,	NULL
we	NULL
next	NULL
examined	NULL
whether	NULL
cellular	NULL
contact	NULL
with	NULL
membrane-bound	NULL
forms	NULL
of	NULL
LT-	NULL
«	NULL
,	NULL
;	NULL
,	NULL
and	NULL
TNF-a	NULL
also	NULL
increased	NULL
HIV-1	NULL
replication	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

We	NULL
constructed	NULL
expression	NULL
vectors	NULL
encoding	NULL
LT-a	NULL
,	NULL
;	NULL
,	NULL
,	NULL
wild-type	NULL
TNF-a	NULL
,	NULL
and	NULL
a	NULL
mutant	NULL
TNF-a	NULL
molecule	NULL
bearing	NULL
a	NULL
disruption	NULL
in	NULL
the	NULL
TNF-a	NULL
proteolytic	NULL
cleavage	NULL
site	NULL
rendering	NULL
it	NULL
TNF	NULL
-	NULL
4	NULL
-	NULL
4	NULL
40	NULL
4	NULL
+	NULL
LTeMB2	NULL
-	NULL
-	NULL
4	NULL
4	NULL
+	NULL
40+	NULL
TNFRS5-Fe	NULL
-	NULL
-	NULL
-	NULL
-	NULL
4	NULL
-	NULL
+	NULL
LTBR-Fe	NULL
-	NULL
-	NULL
-	NULL
-	NULL
-	NULL
4+	NULL
+	NULL
1000007	NULL
E	NULL
&	NULL
a	NULL
.	NULL

&	NULL
100004	NULL
J	NULL
E	NULL
§3	NULL
<	NULL
st	NULL
a	NULL
a	NULL
.	NULL

6	NULL
1000	NULL
?	NULL

g	NULL
E	NULL
5	NULL
E	NULL
O	NULL
100-5	NULL
‘	NULL
FIGURE	NULL
2	NULL
.	NULL

LT-a	NULL
,	NULL
B	NULL
;	NULL
,	NULL
and	NULL
TNF-a	NULL
stimulate	NULL
HIV-1	NULL
replication	NULL
in	NULL
a	NULL
synergistic	NULL
manner	NULL
via	NULL
distinct	NULL
pathways	NULL
.	NULL

U1	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
medium	NULL
alone	NULL
or	NULL
in	NULL
medium	NULL
treated	NULL
with	NULL
TNF-a	NULL
(	NULL
1	NULL
ng/m	NULL
!	NULL
)	NULL

or	NULL
LT-	NULL
«	NULL
;	NULL
B	NULL
;	NULL
,	NULL
(	NULL
10	NULL
ng/m	NULL
!	NULL
)	NULL

plus	NULL
TNF-a	NULL
(	NULL
1	NULL
ng/ml	NULL
)	NULL
.	NULL

Cellular	NULL
supernatants	NULL
were	NULL
harvested	NULL
48	NULL
h	NULL
after	NULL
treatment	NULL
,	NULL
and	NULL
p24	NULL
Ag	NULL
levels	NULL
were	NULL
measured	NULL
in	NULL
duplicate	NULL
samples	NULL
.	NULL

The	NULL
blocking	NULL
of	NULL
HIV-1	NULL
replication	NULL
stimulated	NULL
by	NULL
the	NULL
combination	NULL
of	NULL
LT-a	NULL
,	NULL
B	NULL
;	NULL
(	NULL
10	NULL
ng/m	NULL
!	NULL
)	NULL

and	NULL
TNF-a	NULL
(	NULL
1	NULL
ng/m	NULL
!	NULL
)	NULL

was	NULL
achieved	NULL
with	NULL
5	NULL
pg/ml	NULL
TNFR55-Fc	NULL
(	NULL
TNFR-Fc	NULL
,	NULL
which	NULL
contains	NULL
the	NULL
55-kDa	NULL
TNF	NULL
receptor	NULL
fused	NULL
to	NULL
the	NULL
Fc	NULL
of	NULL
human	NULL
IgG1	NULL
)	NULL
or	NULL
with	NULL
5	NULL
ug/ml	NULL
LT-BRFc	NULL
.	NULL

The	NULL
results	NULL
shown	NULL
are	NULL
consistent	NULL
with	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

The	NULL
error	NULL
bars	NULL
represent	NULL
the	NULL
SD	NULL
between	NULL
duplicate	NULL
values	NULL
in	NULL
the	NULL
experiment	NULL
displayed	NULL
.	NULL

We	NULL
note	NULL
that	NULL
concentrations	NULL
of	NULL
TNF-a	NULL
>	NULL
50	NULL
pM	NULL
are	NULL
cytotoxic	NULL
to	NULL
U1	NULL
cells	NULL
by	NULL
trypan	NULL
blue	NULL
exclusion	NULL
assay	NULL
and	NULL
to	NULL
other	NULL
chronically	NULL
infected	NULL
cell	NULL
lines	NULL
(	NULL
10	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
1	NULL
ng/ml	NULL
(	NULL
~10	NULL
pM	NULL
)	NULL
TNF-a	NULL
was	NULL
used	NULL
,	NULL
since	NULL
it	NULL
was	NULL
not	NULL
cytotoxic	NULL
as	NULL
assayed	NULL
by	NULL
trypan	NULL
blue	NULL
exclusion	NULL
on	NULL
day	NULL
2	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

membrane	NULL
bound	NULL
(	NULL
12	NULL
)	NULL
and	NULL
incapable	NULL
of	NULL
secretion	NULL
to	NULL
a	NULL
soluble	NULL
form	NULL
.	NULL

These	NULL
vectors	NULL
were	NULL
transiently	NULL
transfected	NULL
into	NULL
E293	NULL
cells	NULL
,	NULL
and	NULL
surface	NULL
expression	NULL
of	NULL
the	NULL
molecules	NULL
was	NULL
confirmed	NULL
by	NULL
FACS	NULL
anal-ysis	NULL
.	NULL

Similar	NULL
to	NULL
previous	NULL
results	NULL
(	NULL
45	NULL
)	NULL
,	NULL
at	NULL
least	NULL
50	NULL
%	NULL
of	NULL
the	NULL
cells	NULL
were	NULL
transfected	NULL
and	NULL
,	NULL
in	NULL
general	NULL
,	NULL
>	NULL
75	NULL
%	NULL
were	NULL
transfected	NULL
with	NULL
and	NULL
expressed	NULL
the	NULL
indicated	NULL
construct	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
ensure	NULL
that	NULL
there	NULL
was	NULL
no	NULL
contamination	NULL
by	NULL
LT-a	NULL
;	NULL
in	NULL
the	NULL
coculture	NULL
experiment	NULL
with	NULL
the	NULL
B	NULL
,	NULL
-expressing	NULL
£293	NULL
cells	NULL
,	NULL
we	NULL
cotransfected	NULL
the	NULL
expression	NULL
vector	NULL
along	NULL
with	NULL
the	NULL
expression	NULL
vector	NULL
bearing	NULL
the	NULL
previously	NULL
characterized	NULL
mutation	NULL
DSON	NULL
,	NULL
LT-	NULL
«	NULL
(	NULL
D50N	NULL
)	NULL
.	NULL

The	NULL
(	NULL
LT-	NULL
«	NULL
(	NULL
D50N	NULL
)	NULL
)	NULL
mutation	NULL
abolishes	NULL
the	NULL
ability	NULL
of	NULL
LT-a	NULL
homotrimers	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
TNF-p55	NULL
and	NULL
TNF-p75	NULL
receptors	NULL
,	NULL
and	NULL
hence	NULL
,	NULL
any	NULL
potential	NULL
LT-	NULL
«	NULL
,	NULL
breakdown	NULL
product	NULL
or	NULL
LT-a	NULL
,	NULL
3	NULL
,	NULL
in	NULL
E293	NULL
supernatants	NULL
can	NULL
not	NULL
signal	NULL
(	NULL
38	NULL
)	NULL
.	NULL

We	NULL
note	NULL
that	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
molecule	NULL
to	NULL
bind	NULL
to	NULL
and	NULL
signal	NULL
through	NULL
the	NULL
LT-BR	NULL
(	NULL
38	NULL
)	NULL
is	NULL
not	NULL
affected	NULL
.	NULL

Cocultivation	NULL
of	NULL
£293	NULL
cells	NULL
expressing	NULL
LT-a	NULL
(	NULL
D50N	NULL
)	NULL
,	NULL
B	NULL
,	NULL
(	NULL
designated	NULL
LT-	NULL
&	NULL
f	NULL
in	NULL
the	NULL
figure	NULL
)	NULL
stimulated	NULL
HIV-1	NULL
replication	NULL
in	NULL
contiguous	NULL
U1	NULL
monocytes	NULL
,	NULL
and	NULL
the	NULL
LT-BR	NULL
decoy	NULL
molecule	NULL
specifically	NULL
blocked	NULL
induction	NULL
of	NULL
p24	NULL
production	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
)	NULL
.	NULL

Identical	NULL
results	NULL
were	NULL
obtained	NULL
in	NULL
a	NULL
cocultivation	NULL
experiment	NULL
using	NULL
insect	NULL
cells	NULL
expressing	NULL
LT-	NULL
@	NULL
(	NULL
D50N	NULL
)	NULL
;	NULL
,	NULL
B	NULL
,	NULL
following	NULL
infection	NULL
with	NULL
a	NULL
baculovirus	NULL
vector	NULL
encoding	NULL
LT-	NULL
«	NULL
(	NULL
D50N	NULL
)	NULL
;	NULL
B	NULL
;	NULL
,	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
experiments	NULL
demonstrate	NULL
that	NULL
signaling	NULL
through	NULL
the	NULL
LT-BR	NULL
via	NULL
the	NULL
membrane-bound	NULL
LT-a	NULL
«	NULL
,	NULL
B	NULL
;	NULL
,	NULL
ligand	NULL
stimulates	NULL
HIV-1	NULL
replication	NULL
.	NULL

Cocultivation	NULL
of	NULL
E293	NULL
cells	NULL
expressing	NULL
either	NULL
the	NULL
wild-type	NULL
and	NULL
,	NULL
therefore	NULL
,	NULL
secretable	NULL
TNF-a	NULL
(	NULL
wt-TNF	NULL
)	NULL
or	NULL
the	NULL
membrane-bound	NULL
TNF-a	NULL
(	NULL
mTNF	NULL
)	NULL
molecule	NULL
stimulated	NULL
HIV-1	NULL
replication	NULL
in	NULL
U1	NULL
cells	NULL
to	NULL
a	NULL
similar	NULL
degree	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

In	NULL
both	NULL
cases	NULL
the	NULL
specificity	NULL
of	NULL
this	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
6019	NULL
A	NULL
B	NULL
800	NULL
10000	NULL
E	NULL
=	NULL
-	NULL
8000-€	NULL
€	NULL
€	NULL
,	NULL
soo	NULL
€	NULL
a	NULL
a	NULL
.	NULL

5	NULL
&	NULL
8	NULL
§	NULL
e000-	NULL
&	NULL
3	NULL
<	NULL
-	NULL
400	NULL
B	NULL
E	NULL
3	NULL
9	NULL
B	NULL
4000	NULL
g	NULL
6	NULL
5	NULL
&	NULL
3	NULL
6	NULL
o	NULL
200	NULL
(	NULL
5	NULL
)	NULL
2000	NULL
Z1	NULL
0	NULL
0	NULL
vector	NULL
-	NULL
_	NULL
LTBR-Fe	NULL
control	NULL
50	NULL
1	NULL
&	NULL
%	NULL
)	NULL
;	NULL
&	NULL
{	NULL
0	NULL
&	NULL
+a	NULL
*a.	NULL
antibody	NULL
F	NULL
§	NULL
s	NULL
E	NULL
s	NULL
5	NULL
&	NULL
6	NULL
EEK	NULL
*	NULL
§	NULL
E	NULL
€	NULL
f	NULL
E	NULL
cE	NULL
Ef	NULL
mLTa	NULL
$	NULL
&	NULL
5	NULL
§	NULL
p	NULL
E	NULL
L_	NULL
$	NULL
8	NULL
gg	NULL
9	NULL
j	NULL
WT	NULL
TNF	NULL
mTNF	NULL
C	NULL
D	NULL
40000	NULL
50	NULL
€	NULL
40	NULL
.	NULL

&	NULL
30000	NULL
g	NULL
_	NULL
E	NULL
2	NULL
D	NULL
-	NULL
30-a	NULL
o.	NULL
I3	NULL
3	NULL
g.-	NULL
20000	NULL
F	NULL
_	NULL
h	NULL
E	NULL
20-	NULL
&	NULL
0	NULL
0	NULL
_	NULL
10000	NULL
10-i	NULL
&	NULL
us	NULL
U.	NULL
cel	NULL
0	NULL
H	NULL
3	NULL
Z	NULL
8	NULL
5	NULL
it	NULL
&	NULL
<	NULL
*	NULL
=	NULL
E	NULL
$	NULL
E	NULL
2	NULL
2	NULL
FIGURE	NULL
3	NULL
.	NULL

-	NULL
Soluble	NULL
and	NULL
membrane-bound	NULL
forms	NULL
of	NULL
LT-o	NULL
,	NULL
;	NULL
,	NULL
and	NULL
TNF-	NULL
«	NULL
stimulate	NULL
HIV-1	NULL
replication	NULL
identically	NULL
.	NULL

U1	NULL
cells	NULL
were	NULL
cocultured	NULL
with	NULL
E293	NULL
cells	NULL
transfected	NULL
with	NULL
wt-TNF	NULL
,	NULL
mTNF	NULL
,	NULL
or	NULL
membrane-bound	NULL
LTa	NULL
(	NULL
D5O0N	NULL
)	NULL
,	NULL
B	NULL
,	NULL
(	NULL
mLTaf	NULL
)	NULL
expression	NULL
vector	NULL
,	NULL
and	NULL
p24	NULL
levels	NULL
were	NULL
measured	NULL
in	NULL
the	NULL
supernatants	NULL
after	NULL
48	NULL
h	NULL
of	NULL
coculture	NULL
.	NULL

All	NULL
data	NULL
are	NULL
presented	NULL
as	NULL
the	NULL
mean	NULL
+	NULL
SEM	NULL
of	NULL
at	NULL
least	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

A	NULL
,	NULL
Membrane-bound	NULL
LT-	NULL
&	NULL
,	NULL
3	NULL
,	NULL
stimulates	NULL
HIV	NULL
replication	NULL
.	NULL

U1	NULL
cells	NULL
were	NULL
cocultured	NULL
with	NULL
E293	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
membrane-bound	NULL
LT	NULL
&	NULL
(	NULL
D5ON	NULL
)	NULL
,	NULL
B	NULL
;	NULL
,	NULL
(	NULL
mLTaf	NULL
)	NULL
expression	NULL
vector	NULL
and	NULL
treated	NULL
with	NULL
either	NULL
5	NULL
ug/ml	NULL
LTBR-Fc	NULL
or	NULL
5	NULL
ug/ml	NULL
of	NULL
an	NULL
irrelevant	NULL
Ig-matched	NULL
control	NULL
Ab	NULL
.	NULL

B	NULL
,	NULL
Membrane-bound	NULL
and	NULL
soluble	NULL
TNF-a	NULL
identically	NULL
stimulate	NULL
HIV-1	NULL
replication	NULL
.	NULL

U1	NULL
cells	NULL
were	NULL
cocultured	NULL
with	NULL
E293	NULL
cells	NULL
transfected	NULL
with	NULL
wt-TNF	NULL
,	NULL
mTNF	NULL
,	NULL
membrane-bound	NULL
LTa	NULL
(	NULL
D5ON	NULL
)	NULL
,	NULL
B	NULL
;	NULL
(	NULL
mLTa	NULL
$	NULL
B	NULL
)	NULL
expression	NULL
vectors	NULL
,	NULL
or	NULL
combinations	NULL
thereof	NULL
as	NULL
noted	NULL
.	NULL

The	NULL
anti-TNF-a	NULL
Ab	NULL
cA2	NULL
(	NULL
5	NULL
ug/ml	NULL
!	NULL
)	NULL

was	NULL
used	NULL
to	NULL
block	NULL
the	NULL
effect	NULL
of	NULL
TNF-a	NULL
on	NULL
HIV-1	NULL
replication	NULL
.	NULL

E293	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
vector	NULL
encoding	NULL
the	NULL
wt-TNF-a	NULL
«	NULL
molecule	NULL
expressed	NULL
both	NULL
membrane-bound	NULL
(	NULL
as	NULL
determined	NULL
by	NULL
FACS	NULL
;	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
and	NULL
soluble	NULL
TNF-a	NULL
as	NULL
shown	NULL
in	NULL
C	NULL
and	NULL
D.	NULL
C	NULL
and	NULL
D	NULL
,	NULL
Membrane-bound	NULL
LT-a	NULL
,	NULL
B	NULL
;	NULL
and	NULL
TNF-a	NULL
are	NULL
not	NULL
secreted	NULL
.	NULL

C	NULL
,	NULL
Supernatants	NULL
of	NULL
transfected	NULL
E293	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
U1	NULL
cells	NULL
,	NULL
and	NULL
p24	NULL
levels	NULL
were	NULL
measured	NULL
after	NULL
48	NULL
h.	NULL
D	NULL
,	NULL
Membrane-bound	NULL
LT-o	NULL
,	NULL
3	NULL
;	NULL
and	NULL
TNF-	NULL
«	NULL
are	NULL
not	NULL
secreted	NULL
.	NULL

Forty-eight	NULL
hours	NULL
after	NULL
transfection	NULL
,	NULL
TNF-a	NULL
levels	NULL
were	NULL
measured	NULL
in	NULL
the	NULL
supernatants	NULL
of	NULL
transfected	NULL
E293	NULL
cells	NULL
by	NULL
ELISA	NULL
.	NULL

effect	NULL
was	NULL
demonstrated	NULL
by	NULL
the	NULL
use	NULL
of	NULL
a	NULL
TNF-a	NULL
mAb	NULL
that	NULL
abrogated	NULL
To	NULL
verify	NULL
that	NULL
there	NULL
was	NULL
no	NULL
secreted	NULL
TNF-a	NULL
or	NULL
LT-a	NULL
in	NULL
the	NULL
p24	NULL
induction	NULL
,	NULL
whereas	NULL
a	NULL
control	NULL
IgG1	NULL
isotype-matched	NULL
Ab	NULL
had	NULL
no	NULL
supernatants	NULL
of	NULL
the	NULL
E293	NULL
cells	NULL
that	NULL
expressed	NULL
the	NULL
membrane-bound	NULL
effect	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

LT	NULL
or	NULL
TNF-a	NULL
forms	NULL
,	NULL
we	NULL
cocultivated	NULL
U1	NULL
cells	NULL
with	NULL
supernatants	NULL
When	NULL
E293	NULL
cells	NULL
expressing	NULL
the	NULL
wt-TNF-a	NULL
or	NULL
the	NULL
membrane-	NULL
from	NULL
E293	NULL
cells	NULL
expressing	NULL
these	NULL
molecules	NULL
and	NULL
measured	NULL
p24	NULL
bound	NULL
TNF-	NULL
«	NULL
form	NULL
were	NULL
combined	NULL
with	NULL
E293	NULL
cells	NULL
expressing	NULL
levels	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
exposure	NULL
of	NULL
U1	NULL
cells	NULL
to	NULL
cellular	NULL
supernatants	NULL
membrane-bound	NULL
LT-a	NULL
,	NULL
3	NULL
,	NULL
and	NULL
cocultivated	NULL
with	NULL
U1	NULL
cells	NULL
,	NULL
we	NULL
ob-	NULL
from	NULL
E293	NULL
cells	NULL
expressing	NULL
the	NULL
secretable	NULL
wt-TNF-	NULL
«	NULL
resulted	NULL
in	NULL
served	NULL
a	NULL
similar	NULL
enhancement	NULL
of	NULL
p24	NULL
production	NULL
with	NULL
both	NULL
the	NULL
the	NULL
stimulation	NULL
of	NULL
HIV-1	NULL
replication	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
.	NULL

Supernatants	NULL
from	NULL
soluble	NULL
and	NULL
membrane-bound	NULL
molecules	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

We	NULL
did	NULL
not	NULL
cells	NULL
transfected	NULL
with	NULL
either	NULL
the	NULL
membrane-bound	NULL
TNF-a	NULL
or	NULL
LT	NULL
detect	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
apoptosis	NULL
of	NULL
U1	NULL
cells	NULL
cocultivated	NULL
with	NULL
the	NULL
molecules	NULL
did	NULL
not	NULL
cause	NULL
an	NULL
increase	NULL
in	NULL
p24	NULL
levels	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
.	NULL

Con-cells	NULL
expressing	NULL
membrane-bound	NULL
TNF-a	NULL
versus	NULL
those	NULL
expressing	NULL
sistent	NULL
with	NULL
these	NULL
findings	NULL
,	NULL
an	NULL
ELISA	NULL
of	NULL
the	NULL
supernatants	NULL
measur-wt-TNF-a	NULL
using	NULL
flow	NULL
cytometric	NULL
analysis	NULL
of	NULL
subdiploid	NULL
DNA	NULL
as	NULL
an	NULL
ing	NULL
TNF-a	NULL
levels	NULL
demonstrated	NULL
that	NULL
soluble	NULL
TNF-a	NULL
was	NULL
present	NULL
in	NULL
apoptotic	NULL
marker	NULL
(	NULL
48	NULL
)	NULL
or	NULL
in	NULL
cellular	NULL
viability	NULL
as	NULL
measured	NULL
by	NULL
trypan	NULL
the	NULL
supernatants	NULL
from	NULL
E293	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
wt-TNF-	NULL
@	NULL
blue	NULL
exclusion	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

construct	NULL
but	NULL
not	NULL
in	NULL
the	NULL
supernatants	NULL
of	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
6020	NULL
LT-B	NULL
AND	NULL
TNF-	NULL
«	NULL
STIMULATE	NULL
HIV-1	NULL
REPLICATION	NULL
IN	NULL
U1	NULL
CELLS	NULL
LToIB2	NULL
-	NULL
+	NULL
-	NULL
-	NULL
-	NULL
1250004	NULL
100000-	NULL
750004	NULL
500007	NULL
Conc	NULL
.	NULL

p24	NULL
Antigen	NULL
pg/ml	NULL
250004	NULL
0-LTBR	NULL
LTBR	NULL
+	NULL
VLA-2	NULL
_	NULL
TNFR75	NULL
TNFRTS	NULL
Immobilized	NULL
Antibody	NULL
to	NULL
:	NULL
FIGURE	NULL
4	NULL
.	NULL

Clustering	NULL
of	NULL
LTGB-R	NULL
and	NULL
p75	NULL
TNF-	NULL
«	NULL
receptor	NULL
synergisti-cally	NULL
stimulates	NULL
HIV-1	NULL
replication	NULL
.	NULL

Affinity-purified	NULL
goat	NULL
anti-IgG	NULL
Fc	NULL
was	NULL
immobilized	NULL
on	NULL
24-well	NULL
plates	NULL
,	NULL
incubated	NULL
with	NULL
the	NULL
Abs	NULL
indicated	NULL
,	NULL
and	NULL
overlaid	NULL
with	NULL
U1	NULL
cells	NULL
for	NULL
48	NULL
h	NULL
,	NULL
and	NULL
the	NULL
HIV-1	NULL
p24	NULL
Ag	NULL
concentration	NULL
was	NULL
measured	NULL
.	NULL

As	NULL
a	NULL
control	NULL
for	NULL
U1	NULL
cell	NULL
responsiveness	NULL
,	NULL
stimulation	NULL
of	NULL
p24	NULL
production	NULL
by	NULL
soluble	NULL
LT-a	NULL
,	NULL
B	NULL
;	NULL
,	NULL
ligand	NULL
at	NULL
50	NULL
ng/ml	NULL
was	NULL
also	NULL
performed	NULL
.	NULL

The	NULL
results	NULL
shown	NULL
are	NULL
consistent	NULL
with	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

The	NULL
error	NULL
bars	NULL
represent	NULL
the	NULL
SD	NULL
between	NULL
duplicate	NULL
values	NULL
in	NULL
the	NULL
experiment	NULL
displayed	NULL
.	NULL

We	NULL
note	NULL
that	NULL
U1	NULL
cells	NULL
undergo	NULL
a	NULL
time-dependent	NULL
decay	NULL
in	NULL
the	NULL
ability	NULL
of	NULL
LT-a	NULL
,	NULL
B	NULL
;	NULL
to	NULL
induce	NULL
HIV-1	NULL
replication	NULL
as	NULL
noted	NULL
previously	NULL
for	NULL
TNF-a	NULL
(	NULL
34	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
addition	NULL
of	NULL
LT-a	NULL
,	NULL
B	NULL
;	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
50	NULL
ng/m	NULL
!	NULL

resulted	NULL
in	NULL
variable	NULL
activation	NULL
of	NULL
HIV-1	NULL
replication	NULL
in	NULL
the	NULL
U1	NULL
clone	NULL
similar	NULL
to	NULL
that	NULL
after	NULL
addition	NULL
of	NULL
the	NULL
ligand	NULL
at	NULL
10	NULL
ng/ml	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

membrane-bound	NULL
TNF-a	NULL
@	NULL
or	NULL
LT-	NULL
«	NULL
fB	NULL
constructs	NULL
(	NULL
Fig	NULL
.	NULL

3D	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
specific	NULL
engagement	NULL
of	NULL
the	NULL
TNF-a	NULL
and	NULL
LT-B	NULL
receptors	NULL
by	NULL
their	NULL
respective	NULL
membrane-bound	NULL
ligands	NULL
caused	NULL
the	NULL
observed	NULL
up-regulation	NULL
of	NULL
p24	NULL
production	NULL
.	NULL

Clustering	NULL
of	NULL
LT-BR	NULL
and	NULL
TNFp75R	NULL
cooperatively	NULL
enhances	NULL
HIV-1	NULL
replication	NULL
TNF-a	NULL
appears	NULL
to	NULL
signal	NULL
through	NULL
the	NULL
clustering	NULL
of	NULL
its	NULL
cognate	NULL
receptors	NULL
,	NULL
p55	NULL
and	NULL
p75	NULL
(	NULL
11	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
an	NULL
anti-LT-BR	NULL
agonist	NULL
Ab	NULL
,	NULL
which	NULL
clusters	NULL
the	NULL
LT-BR	NULL
,	NULL
can	NULL
elicit	NULL
LT-BR-mediated	NULL
biological	NULL
functions	NULL
in	NULL
tissue	NULL
culture	NULL
(	NULL
39	NULL
,	NULL
48	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
specific	NULL
clustering	NULL
of	NULL
the	NULL
LT-BR	NULL
on	NULL
the	NULL
surface	NULL
of	NULL
U1	NULL
cells	NULL
also	NULL
stimulated	NULL
HIV-1	NULL
replication	NULL
,	NULL
as	NULL
did	NULL
clustering	NULL
of	NULL
the	NULL
p75	NULL
TNF	NULL
receptor	NULL
.	NULL

By	NULL
contrast	NULL
,	NULL
a	NULL
control	NULL
Ig-matched	NULL
Ab	NULL
did	NULL
not	NULL
increase	NULL
p24	NULL
levels	NULL
above	NULL
baseline	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Notably	NULL
,	NULL
simultaneous	NULL
clustering	NULL
of	NULL
both	NULL
LT-BR	NULL
and	NULL
p75	NULL
TNF	NULL
receptor	NULL
resulted	NULL
in	NULL
a	NULL
marked	NULL
enhancement	NULL
of	NULL
HIV-1	NULL
replication	NULL
compared	NULL
with	NULL
that	NULL
after	NULL
engagement	NULL
of	NULL
either	NULL
receptor	NULL
alone	NULL
.	NULL

Thus	NULL
,	NULL
soluble	NULL
and	NULL
membrane-bound	NULL
forms	NULL
of	NULL
LT-a	NULL
,	NULL
3	NULL
,	NULL
and	NULL
TNF-a	NULL
or	NULL
the	NULL
specific	NULL
engagement	NULL
of	NULL
their	NULL
cognate	NULL
receptors	NULL
result	NULL
in	NULL
cooperative	NULL
stimulation	NULL
of	NULL
HIV-1	NULL
replication	NULL
.	NULL

TNF-a	NULL
,	NULL
but	NULL
not	NULL
induces	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
in	NULL
UI	NULL
cells	NULL
TNF-a	NULL
«	NULL
causes	NULL
the	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
reviewed	NULL
in	NULL
Ref	NULL
.	NULL

49	NULL
)	NULL
,	NULL
and	NULL
the	NULL
binding	NULL
of	NULL
NF-KB	NULL
to	NULL
the	NULL
HIV-LTR	NULL
is	NULL
thought	NULL
to	NULL
mediate	NULL
TNF-	NULL
«	NULL
-induced	NULL
HIV-1	NULL
gene	NULL
transcription	NULL
and	NULL
replication	NULL
in	NULL
U1	NULL
cells	NULL
(	NULL
33	NULL
)	NULL
.	NULL

In	NULL
some	NULL
cell	NULL
lines	NULL
LT-a	NULL
;	NULL
3	NULL
,	NULL
also	NULL
causes	NULL
the	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
48	NULL
,	NULL
50	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
we	NULL
explored	NULL
whether	NULL
the	NULL
mechanism	NULL
of	NULL
LT-	NULL
«	NULL
,	NULL
3	NULL
,	NULL
-mediated	NULL
stimulation	NULL
of	NULL
HIV-1	NULL
replication	NULL
in	NULL
U1	NULL
cells	NULL
involved	NULL
NF-KB	NULL
.	NULL

Specifically	NULL
,	NULL
we	NULL
stimulated	NULL
U1	NULL
cells	NULL
r	NULL
--	NULL
HIV-	NULL
«	NULL
B	NULL
-	NULL
_	NULL
--	NULL
-61/-27-	NULL
NFB	NULL
PAJ	NULL
U4	NULL
|	NULL
h	NULL
id	NULL
u	NULL
1	NULL
2	NULL
8	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
FIGURE	NULL
5	NULL
.	NULL

TNF-a	NULL
,	NULL
but	NULL
not	NULL
LT-	NULL
@	NULL
,	NULL
;	NULL
,	NULL
stimulates	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
in	NULL
U1	NULL
cells	NULL
.	NULL

An	NULL
EMSA	NULL
using	NULL
nuclear	NULL
extracts	NULL
from	NULL
unstimulated	NULL
UI	NULL
cells	NULL
(	NULL
un	NULL
)	NULL
or	NULL
cells	NULL
stimulated	NULL
with	NULL
100	NULL
U/ml	NULL
TNF-a	NULL
and/or	NULL
50	NULL
ng/ml	NULL
LT-a	NULL
,	NULL
B	NULL
;	NULL
for	NULL
2	NULL
h	NULL
as	NULL
indicated	NULL
.	NULL

A	NULL
TNF	NULL
--	NULL
inducible	NULL
complex	NULL
binds	NULL
to	NULL
the	NULL
HIV-1-NFxB	NULL
site	NULL
oligonucleotide	NULL
probe	NULL
(	NULL
Zanes	NULL
I	NULL
and	NULL
2	NULL
)	NULL
,	NULL
whereas	NULL
there	NULL
is	NULL
no	NULL
inducible	NULL
complex	NULL
observed	NULL
after	NULL
LT-	NULL
@	NULL
,	NULL
B	NULL
;	NULL
stimulation	NULL
.	NULL

An	NULL
oligonucleotide	NULL
probe	NULL
matching	NULL
the	NULL
sequences	NULL
spanning	NULL
between	NULL
-61	NULL
and	NULL
-28	NULL
relative	NULL
to	NULL
the	NULL
human	NULL
TNF-a	NULL
cap	NULL
site	NULL
containing	NULL
an	NULL
Spl	NULL
site	NULL
was	NULL
used	NULL
as	NULL
a	NULL
control	NULL
for	NULL
protein	NULL
loading	NULL
and	NULL
processing	NULL
of	NULL
the	NULL
EMSA	NULL
.	NULL

The	NULL
experiment	NULL
displayed	NULL
is	NULL
representative	NULL
of	NULL
three	NULL
experiments	NULL
performed	NULL
in	NULL
three	NULL
independent	NULL
U1	NULL
clones	NULL
.	NULL

We	NULL
note	NULL
that	NULL
HIV-1	NULL
p24	NULL
levels	NULL
were	NULL
inducible	NULL
by	NULL
both	NULL
TNF-a	NULL
and	NULL
LT-a	NULL
,	NULL
B	NULL
;	NULL
in	NULL
all	NULL
three	NULL
clones	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

with	NULL
LT-	NULL
«	NULL
,	NULL
3	NULL
,	NULL
and/or	NULL
TNF-a	NULL
,	NULL
prepared	NULL
nuclear	NULL
extracts	NULL
,	NULL
and	NULL
performed	NULL
an	NULL
EMSA	NULL
using	NULL
an	NULL
NF-KB	NULL
site	NULL
from	NULL
the	NULL
HIV-1	NULL
LTR	NULL
as	NULL
a	NULL
probe	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
TNF-a	NULL
caused	NULL
the	NULL
induction	NULL
of	NULL
NF-kB	NULL
binding	NULL
activity	NULL
(	NULL
Zanes	NULL
2	NULL
and	NULL
4	NULL
)	NULL
,	NULL
whereas	NULL
treatment	NULL
with	NULL
LT-o	NULL
,	NULL
B	NULL
,	NULL
at	NULL
concentrations	NULL
that	NULL
stimulate	NULL
an	NULL
increase	NULL
in	NULL
p24	NULL
production	NULL
did	NULL
not	NULL
result	NULL
in	NULL
detectable	NULL
inducible	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
(	NULL
Zane	NULL
3	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
observed	NULL
cooperation	NULL
between	NULL
and	NULL
TNF-	NULL
@	NULL
raises	NULL
the	NULL
possibility	NULL
that	NULL
another	NULL
undefined	NULL
HIV-1	NULL
transcriptional	NULL
activation	NULL
pathway	NULL
is	NULL
stimulated	NULL
via	NULL
the	NULL
LT-BR	NULL
receptor	NULL
.	NULL

HIV-1	NULL
infection	NULL
stimulates	NULL
LT-a	NULL
,	NULL
B	NULL
;	NULL
expression	NULL
on	NULL
the	NULL
surface	NULL
of	NULL
H9	NULL
T	NULL
cells	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
HIV-1	NULL
infection	NULL
up-regulates	NULL
LT-	NULL
«	NULL
,	NULL
B	NULL
;	NULL
,	NULL
expression	NULL
on	NULL
T	NULL
cells	NULL
,	NULL
we	NULL
screened	NULL
a	NULL
panel	NULL
of	NULL
T	NULL
cell	NULL
lines	NULL
for	NULL
the	NULL
effect	NULL
of	NULL
HIV-1	NULL
infection	NULL
on	NULL
surface	NULL
expression	NULL
of	NULL
LT-a	NULL
,	NULL
,	NULL
.	NULL

We	NULL
infected	NULL
the	NULL
T	NULL
cell	NULL
hybridoma	NULL
I-23	NULL
and	NULL
the	NULL
T	NULL
cell	NULL
lines	NULL
CEM	NULL
,	NULL
Jurkat	NULL
,	NULL
and	NULL
H9	NULL
with	NULL
the	NULL
HIV-1	NULL
MN	NULL
strain	NULL
at	NULL
a	NULL
multiplicity	NULL
of	NULL
infection	NULL
of	NULL
1.0	NULL
and	NULL
analyzed	NULL
these	NULL
cells	NULL
4	NULL
days	NULL
later	NULL
by	NULL
flow	NULL
cytometry	NULL
for	NULL
surface	NULL
LT-a	NULL
,	NULL
B	NULL
,	NULL
expression	NULL
.	NULL

HIV-1	NULL
infection	NULL
did	NULL
not	NULL
induce	NULL
LT-a	NULL
,	NULL
3	NULL
,	NULL
surface	NULL
expression	NULL
on	NULL
CEM	NULL
,	NULL
Jurkat	NULL
,	NULL
or	NULL
I-23	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

However	NULL
,	NULL
in	NULL
the	NULL
case	NULL
of	NULL
the	NULL
H9	NULL
cell	NULL
line	NULL
,	NULL
HIV-1	NULL
infection	NULL
did	NULL
cause	NULL
a	NULL
reproducible	NULL
increase	NULL
in	NULL
LT-a	NULL
,	NULL
B	NULL
,	NULL
surface	NULL
expression	NULL
4	NULL
days	NULL
after	NULL
infection	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
,	NULL
whereas	NULL
HIV-1	NULL
infection	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
surface	NULL
TNF-a	NULL
expression	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
demonstrate	NULL
that	NULL
the	NULL
functional	NULL
LT-a	NULL
,	NULL
f	NULL
,	NULL
heterotrimer	NULL
is	NULL
specifically	NULL
up-regulated	NULL
by	NULL
HIV-1	NULL
infection	NULL
,	NULL
we	NULL
stained	NULL
H9	NULL
cells	NULL
with	NULL
the	NULL
Abs	NULL
NC2	NULL
and	NULL
CH12	NULL
.	NULL

The	NULL
NC2	NULL
Ab	NULL
recognizes	NULL
all	NULL
forms	NULL
,	NULL
whereas	NULL
CH12	NULL
specifically	NULL
recognizes	NULL
the	NULL
surface	NULL
LT-	NULL
@	NULL
,	NULL
fB	NULL
;	NULL
forms	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
the	NULL
NCZ	NULL
Ab	NULL
,	NULL
but	NULL
not	NULL
the	NULL
CH12	NULL
Ab	NULL
,	NULL
recognizes	NULL
the	NULL
inducible	NULL
LT	NULL
complex	NULL
,	NULL
indicating	NULL
that	NULL
B	NULL
;	NULL
,	NULL
is	NULL
up-regulated	NULL
by	NULL
HIV-1	NULL
infection	NULL
of	NULL
H9	NULL
cells	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
6021	NULL
HIV	NULL
-	NULL
HIV+	NULL
a	NULL
o	NULL
a	NULL
@	NULL
[	NULL
sd	NULL
0	NULL
©	NULL
&	NULL
-	NULL
©	NULL
©	NULL
@	NULL
LT-BRFe	NULL
-	NULL
#	NULL
``	NULL
27	NULL
5	NULL
5	NULL
0	NULL
0	NULL
68	NULL
0	NULL
%	NULL
40	NULL
FIGURE	NULL
6	NULL
.	NULL

HIV-1	NULL
infection	NULL
stimu-	NULL
0	NULL
1s	NULL
lates	NULL
LT-a	NULL
,	NULL
B	NULL
,	NULL
expression	NULL
on	NULL
the	NULL
surface	NULL
of	NULL
T	NULL
cells	NULL
.	NULL

Flow	NULL
cytometric	NULL
analysis	NULL
of	NULL
HIV-1	NULL
infected	NULL
T	NULL
cells	NULL
(	NULL
HIV	NULL
*	NULL
)	NULL
was	NULL
performed	NULL
on	NULL
day	NULL
4	NULL
postinfection	NULL
.	NULL

HIV	NULL
(	NULL
-	NULL
)	NULL
40	NULL
10	NULL
FL1-Height	NULL
8	NULL
o	NULL
curves	NULL
denote	NULL
expression	NULL
on	NULL
&	NULL
a	NULL
uninfected	NULL
H9	NULL
cells	NULL
.	NULL

The	NULL
left-most	NULL
curve	NULL
©	NULL
$	NULL
represents	NULL
negative	NULL
control	NULL
staining	NULL
with	NULL
~	NULL
~	NULL
isotype-matched	NULL
control	NULL
and	NULL
secondary	NULL
a	NULL
8	NULL
in	NULL
g	NULL
FITC-labeled	NULL
Ab	NULL
.	NULL

In	NULL
the	NULL
top	NULL
panel	NULL
,	NULL
cells	NULL
NC2	NULL
5.	NULL
g	NULL
were	NULL
stained	NULL
with	NULL
LT-BRFc	NULL
followed	NULL
by	NULL
o	NULL
®	NULL
08	NULL
FITC-labeled	NULL
goat	NULL
anti-human	NULL
Ig	NULL
.	NULL

In	NULL
the	NULL
o	NULL
o	NULL
middle	NULL
and	NULL
bottom	NULL
panels	NULL
,	NULL
the	NULL
Abs	NULL
NC2	NULL
T	NULL
T	NULL
and	NULL
CH12	NULL
,	NULL
which	NULL
respectively	NULL
recognize	NULL
ol	NULL
.	NULL

|	NULL
o	NULL
either	NULL
all	NULL
LT-	NULL
&	NULL
-containing	NULL
forms	NULL
or	NULL
only	NULL
10	NULL
10	NULL
)	NULL
10°	NULL
10°	NULL
104	NULL
10°	NULL
10	NULL
)	NULL
102	NULL
10	NULL
A	NULL
64	NULL
the	NULL
LT-	NULL
,	NULL
fB	NULL
,	NULL
form	NULL
of	NULL
surface	NULL
LT	NULL
,	NULL
were	NULL
FL1-Height	NULL
FL1-Height	NULL
used	NULL
.	NULL

The	NULL
experiment	NULL
displayed	NULL
is	NULL
representative	NULL
of	NULL
eight	NULL
independent	NULL
experiments	NULL
.	NULL

3	NULL
g	NULL
Bo	NULL
Bl	NULL
s	NULL
s	NULL
2	NULL
g	NULL
“	NULL
a	NULL
8-s	NULL
5	NULL
CH12	NULL
i	NULL
6s	NULL
40	NULL
Discussion	NULL
We	NULL
have	NULL
shown	NULL
that	NULL
HIV-1	NULL
replication	NULL
can	NULL
be	NULL
triggered	NULL
by	NULL
LT-BR	NULL
activation	NULL
alone	NULL
and	NULL
that	NULL
it	NULL
is	NULL
cooperatively	NULL
stimulated	NULL
when	NULL
the	NULL
distinct	NULL
LT-BR	NULL
and	NULL
TNF	NULL
receptor	NULL
systems	NULL
are	NULL
simultaneously	NULL
engaged	NULL
on	NULL
monocytes	NULL
.	NULL

Monocytes	NULL
and	NULL
the	NULL
monocytic	NULL
dendritic/re-ticular	NULL
network	NULL
of	NULL
cells	NULL
bear	NULL
the	NULL
CCR5	NULL
chemokine	NULL
receptor	NULL
,	NULL
which	NULL
is	NULL
used	NULL
by	NULL
HIV-1	NULL
for	NULL
cellular	NULL
entry	NULL
(	NULL
51-53	NULL
)	NULL
.	NULL

In	NULL
the	NULL
secondary	NULL
lymphoid	NULL
tissues	NULL
,	NULL
dendritic	NULL
cells	NULL
can	NULL
sequester	NULL
up	NULL
to	NULL
90	NULL
%	NULL
of	NULL
the	NULL
total	NULL
HIV-1	NULL
viral	NULL
burden	NULL
on	NULL
their	NULL
cellular	NULL
surfaces	NULL
(	NULL
30	NULL
)	NULL
and	NULL
are	NULL
important	NULL
in	NULL
transmitting	NULL
HIV-1	NULL
to	NULL
T	NULL
cells	NULL
(	NULL
54	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
our	NULL
demonstration	NULL
that	NULL
LT-a	NULL
,	NULL
B	NULL
,	NULL
and	NULL
TNF-a	NULL
@	NULL
cooperatively	NULL
stimulate	NULL
HIV-1	NULL
replication	NULL
may	NULL
suggest	NULL
an	NULL
important	NULL
host	NULL
mechanism	NULL
for	NULL
regulating	NULL
HIV-1	NULL
viral	NULL
burden	NULL
in	NULL
monocytic	NULL
cells	NULL
,	NULL
which	NULL
are	NULL
critical	NULL
to	NULL
HIV-1	NULL
infection	NULL
and	NULL
progression	NULL
.	NULL

Interestingly	NULL
,	NULL
activation	NULL
of	NULL
the	NULL
LT-BR	NULL
potentiates	NULL
TNF-	NULL
«	NULL
-medi-ated	NULL
cell	NULL
death	NULL
(	NULL
55	NULL
)	NULL
,	NULL
providing	NULL
a	NULL
precedent	NULL
for	NULL
cooperative	NULL
interactions	NULL
between	NULL
the	NULL
two	NULL
receptor	NULL
systems	NULL
.	NULL

In	NULL
certain	NULL
cell	NULL
types	NULL
,	NULL
LT-BR	NULL
signaling	NULL
results	NULL
in	NULL
NF-KB	NULL
activation	NULL
via	NULL
the	NULL
recruitment	NULL
of	NULL
TNF	NULL
receptor-associated	NULL
factor-3	NULL
(	NULL
TRAF3	NULL
)	NULL
and	NULL
-5	NULL
(	NULL
56	NULL
)	NULL
.	NULL

NF-kB	NULL
translocation	NULL
secondary	NULL
to	NULL
TNFR	NULL
p55	NULL
signaling	NULL
involves	NULL
TRAF2	NULL
(	NULL
57	NULL
)	NULL
,	NULL
and	NULL
TRAF1	NULL
is	NULL
involved	NULL
in	NULL
TNFR	NULL
p75-induced	NULL
NF-	NULL
«	NULL
B	NULL
modulation	NULL
(	NULL
58	NULL
)	NULL
.	NULL

We	NULL
were	NULL
not	NULL
able	NULL
to	NULL
detect	NULL
LT-BR-mediated	NULL
induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
U1	NULL
cells	NULL
,	NULL
suggesting	NULL
that	NULL
either	NULL
the	NULL
levels	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
induced	NULL
by	NULL
the	NULL
LT-BR	NULL
in	NULL
U1	NULL
cells	NULL
are	NULL
too	NULL
low	NULL
for	NULL
detection	NULL
40	NULL
3	NULL
'	NULL
A	NULL
on	NULL
00	NULL
Vh	NULL
O	NULL
C3	NULL
1	NULL
2	NULL
10	NULL
10	NULL
10	NULL
10	NULL
10	NULL
FL1-Height	NULL
10	NULL
FL1-Height	NULL
by	NULL
EMSA	NULL
or	NULL
that	NULL
HIV-1	NULL
stimulation	NULL
by	NULL
LT-BR	NULL
may	NULL
be	NULL
NF-	NULL
«	NULL
B	NULL
independent	NULL
.	NULL

These	NULL
results	NULL
are	NULL
consistent	NULL
with	NULL
the	NULL
observation	NULL
that	NULL
synergistic	NULL
activation	NULL
of	NULL
HIV	NULL
replication	NULL
by	NULL
other	NULL
cytokine	NULL
combinations	NULL
acts	NULL
at	NULL
different	NULL
transcriptional	NULL
and	NULL
post-transcriptional	NULL
steps	NULL
in	NULL
the	NULL
HIV-1	NULL
life	NULL
cycle	NULL
(	NULL
7	NULL
)	NULL
.	NULL

Notably	NULL
,	NULL
the	NULL
LT-BR-stimulated	NULL
pathway	NULL
differs	NULL
from	NULL
that	NULL
mediated	NULL
by	NULL
the	NULL
TNF	NULL
receptors	NULL
in	NULL
that	NULL
it	NULL
is	NULL
mediated	NULL
by	NULL
different	NULL
intracellular	NULL
TRAFs	NULL
.	NULL

Perhaps	NULL
in	NULL
the	NULL
case	NULL
of	NULL
HIV-1	NULL
replication	NULL
,	NULL
the	NULL
recruitment	NULL
of	NULL
a	NULL
different	NULL
set	NULL
of	NULL
TRAFs	NULL
by	NULL
the	NULL
LT-BR	NULL
results	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
a	NULL
distinct	NULL
signal	NULL
transduction	NULL
pathway	NULL
that	NULL
is	NULL
complementary	NULL
to	NULL
the	NULL
signal	NULL
transduction	NULL
pathways	NULL
activated	NULL
by	NULL
TNF-	NULL
@	NULL
.	NULL

The	NULL
results	NULL
of	NULL
our	NULL
cocultivation	NULL
experiments	NULL
with	NULL
6293	NULL
cells	NULL
expressing	NULL
membrane-bound	NULL
TNF-a	NULL
are	NULL
in	NULL
contrast	NULL
to	NULL
results	NULL
obtained	NULL
in	NULL
another	NULL
study	NULL
using	NULL
CHO	NULL
or	NULL
3T3	NULL
cells	NULL
stably	NULL
transfected	NULL
with	NULL
a	NULL
membrane-bound	NULL
form	NULL
of	NULL
TNF-a	NULL
and	NULL
then	NULL
cocultured	NULL
with	NULL
latently	NULL
infected	NULL
ACH-2	NULL
T	NULL
cells	NULL
or	NULL
HIV-1-infected	NULL
PBLs	NULL
(	NULL
59	NULL
)	NULL
.	NULL

In	NULL
this	NULL
study	NULL
the	NULL
target	NULL
cells	NULL
appeared	NULL
to	NULL
preferentially	NULL
undergo	NULL
apoptosis	NULL
and	NULL
down-regulation	NULL
of	NULL
HIV-1	NULL
replication	NULL
when	NULL
they	NULL
were	NULL
cocultivated	NULL
with	NULL
a	NULL
membrane-anchored	NULL
form	NULL
of	NULL
TNF-a	NULL
.	NULL

The	NULL
differences	NULL
between	NULL
this	NULL
study	NULL
and	NULL
ours	NULL
might	NULL
be	NULL
attributed	NULL
to	NULL
the	NULL
fact	NULL
that	NULL
in	NULL
the	NULL
study	NULL
by	NULL
Lazdins	NULL
et	NULL
al	NULL
.	NULL

100	NULL
%	NULL
of	NULL
the	NULL
stably	NULL
transfected	NULL
CHO	NULL
and	NULL
3T3	NULL
cells	NULL
would	NULL
be	NULL
expected	NULL
to	NULL
express	NULL
membrane-bound	NULL
TNF-a	NULL
@	NULL
.	NULL

Since	NULL
a	NULL
wt-TNF-a	NULL
@	NULL
-expressing	NULL
cell	NULL
line	NULL
was	NULL
not	NULL
employed	NULL
in	NULL
their	NULL
cocultivation	NULL
experiments	NULL
as	NULL
a	NULL
control	NULL
,	NULL
it	NULL
is	NULL
not	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
6022	NULL
LT-B	NULL
AND	NULL
TNF-	NULL
«	NULL
STIMULATE	NULL
HIV-1	NULL
REPLICATION	NULL
IN	NULL
U1	NULL
CELLS	NULL
possible	NULL
to	NULL
determine	NULL
whether	NULL
the	NULL
level	NULL
of	NULL
TNF-a	NULL
expression	NULL
in	NULL
the	NULL
transfected	NULL
cells	NULL
was	NULL
toxic	NULL
to	NULL
the	NULL
HIV-1-infected	NULL
cells	NULL
,	NULL
thus	NULL
causing	NULL
cell	NULL
death	NULL
.	NULL

Since	NULL
HIV-1-infected	NULL
monocytes	NULL
are	NULL
particularly	NULL
numerous	NULL
in	NULL
lymph	NULL
nodes	NULL
and	NULL
spleen	NULL
,	NULL
where	NULL
they	NULL
are	NULL
in	NULL
intimate	NULL
contact	NULL
with	NULL
T	NULL
cells	NULL
in	NULL
the	NULL
early	NULL
stages	NULL
of	NULL
HIV-1	NULL
infection	NULL
(	NULL
31	NULL
)	NULL
,	NULL
it	NULL
is	NULL
intriguing	NULL
to	NULL
speculate	NULL
that	NULL
activated	NULL
lymphocytes	NULL
expressing	NULL
surface	NULL
LT-	NULL
,	NULL
B	NULL
;	NULL
,	NULL
or	NULL
TNF-a	NULL
forms	NULL
may	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
promoting	NULL
HIV-1	NULL
replication	NULL
in	NULL
contiguous	NULL
monocytes	NULL
.	NULL

Early	NULL
HIV-1	NULL
infection	NULL
is	NULL
characterized	NULL
by	NULL
lymphadenopathy	NULL
(	NULL
29	NULL
,	NULL
60	NULL
)	NULL
,	NULL
splenomegaly	NULL
,	NULL
and	NULL
lymphocyte	NULL
activation	NULL
(	NULL
61-63	NULL
)	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
disturbances	NULL
of	NULL
lymphoid	NULL
organs	NULL
are	NULL
among	NULL
the	NULL
earliest	NULL
changes	NULL
observed	NULL
in	NULL
HIV-1	NULL
infection	NULL
(	NULL
31	NULL
,	NULL
30	NULL
,	NULL
64	NULL
)	NULL
.	NULL

However	NULL
,	NULL
as	NULL
HIV-1	NULL
infection	NULL
progresses	NULL
with	NULL
concomitant	NULL
T	NULL
cell	NULL
death	NULL
,	NULL
the	NULL
total	NULL
lymphoid	NULL
tissue	NULL
in	NULL
the	NULL
infected	NULL
host	NULL
dramatically	NULL
decreases	NULL
(	NULL
29	NULL
,	NULL
65	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
perturbations	NULL
of	NULL
the	NULL
LT-	NULL
«	NULL
,	NULL
,	NULL
and	NULL
TNF-a	NULL
ligand	NULL
receptor	NULL
systems	NULL
also	NULL
cause	NULL
disturbances	NULL
in	NULL
the	NULL
lymphoid	NULL
cells	NULL
and	NULL
organs	NULL
.	NULL

The	NULL
LT-B	NULL
signaling	NULL
pathway	NULL
is	NULL
required	NULL
for	NULL
lymph	NULL
node	NULL
organogenesis	NULL
and	NULL
lymphoid	NULL
architecture	NULL
in	NULL
the	NULL
developing	NULL
mouse	NULL
,	NULL
and	NULL
the	NULL
loss	NULL
of	NULL
LT-B	NULL
signaling	NULL
in	NULL
normal	NULL
adult	NULL
mice	NULL
leads	NULL
to	NULL
an	NULL
altered	NULL
splenic	NULL
marginal	NULL
zone	NULL
and	NULL
the	NULL
collapse	NULL
of	NULL
follicular	NULL
dendritic	NULL
cell	NULL
(	NULL
FDC	NULL
)	NULL
networks	NULL
in	NULL
both	NULL
spleen	NULL
and	NULL
lymph	NULL
nodes	NULL
(	NULL
18	NULL
,	NULL
22	NULL
)	NULL
.	NULL

TNF-a	NULL
is	NULL
also	NULL
involved	NULL
in	NULL
the	NULL
generation	NULL
of	NULL
FDCs	NULL
and	NULL
the	NULL
formation	NULL
of	NULL
splenic	NULL
germinal	NULL
centers	NULL
and	NULL
functions	NULL
as	NULL
an	NULL
autocrine	NULL
B	NULL
cell	NULL
growth	NULL
factor	NULL
(	NULL
24-28	NULL
)	NULL
.	NULL

Perhaps	NULL
early	NULL
in	NULL
HIV-1	NULL
infection	NULL
,	NULL
the	NULL
up-regulation	NULL
of	NULL
LT-a	NULL
,	NULL
B	NULL
;	NULL
,	NULL
together	NULL
with	NULL
membrane-bound	NULL
TNF-a	NULL
in	NULL
HIV-1-infected	NULL
lymphocytes	NULL
acts	NULL
to	NULL
stimulate	NULL
lymphoid	NULL
proliferation	NULL
and	NULL
dendritic	NULL
cell	NULL
maturation	NULL
.	NULL

It	NULL
is	NULL
interesting	NULL
to	NULL
speculate	NULL
that	NULL
as	NULL
rounds	NULL
of	NULL
HIV-1	NULL
replication	NULL
are	NULL
cooperatively	NULL
driven	NULL
by	NULL
the	NULL
TNF-	NULL
«	NULL
@	NULL
and	NULL
LT-o	NULL
,	NULL
B	NULL
,	NULL
signaling	NULL
pathways	NULL
,	NULL
and	NULL
HIV-1	NULL
infection	NULL
progresses	NULL
to	NULL
AIDS	NULL
,	NULL
the	NULL
virus	NULL
destroys	NULL
LT-a	NULL
,	NULL
,	NULL
-bearing	NULL
T	NULL
cells	NULL
and	NULL
a	NULL
crucial	NULL
lymphoid	NULL
architectural	NULL
signal	NULL
is	NULL
lost	NULL
.	NULL

Acknowledgments	NULL
We	NULL
thank	NULL
Katherine	NULL
Hanify	NULL
for	NULL
technical	NULL
assistance	NULL
and	NULL
those	NULL
at	NULL
Biogen	NULL
whose	NULL
efforts	NULL
led	NULL
to	NULL
the	NULL
development	NULL
and	NULL
characterization	NULL
of	NULL
the	NULL
LT	NULL
reagents	NULL
.	NULL

We	NULL
thank	NULL
Fabienne	NULL
Mackay	NULL
,	NULL
Paula	NULL
Hochman	NULL
,	NULL
and	NULL
Evelyn	NULL
Kurt-Jones	NULL
for	NULL
helpful	NULL
discussions	NULL
and	NULL
Carl	NULL
Ware	NULL
,	NULL
Bruce	NULL
Walker	NULL
,	NULL
and	NULL
anonymous	NULL
reviewers	NULL
for	NULL
helpful	NULL
comments	NULL
on	NULL
the	NULL
manuscript	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
Centocor	NULL
,	NULL
Hoffmann-La	NULL
Roche	NULL
,	NULL
Werner	NULL
Lesslauer	NULL
,	NULL
George	NULL
Kollias	NULL
,	NULL
and	NULL
Jeff	NULL
Bergelson	NULL
for	NULL
the	NULL
generous	NULL
gifts	NULL
of	NULL
reagents	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Mellors	NULL
,	NULL
J.	NULL
,	NULL
C.	NULL
Rinaldo	NULL
,	NULL
P.	NULL
Gupta	NULL
,	NULL
R.	NULL
White	NULL
,	NULL
J.	NULL
Todd	NULL
,	NULL
and	NULL
L.	NULL
Kingsley	NULL
.	NULL

1996	NULL
.	NULL

Prognosis	NULL
in	NULL
HIV-1	NULL
infection	NULL
predicted	NULL
by	NULL
the	NULL
quantity	NULL
of	NULL
virus	NULL
in	NULL
plasma	NULL
.	NULL

Science	NULL
272:1167	NULL
.	NULL

2	NULL
.	NULL

Shearer	NULL
,	NULL
W.	NULL
,	NULL
T.	NULL
Quinn	NULL
,	NULL
P.	NULL
LaRussa	NULL
,	NULL
J.	NULL
Lew	NULL
,	NULL
and	NULL
W.	NULL
S.	NULL
Group	NULL
.	NULL

1997	NULL
.	NULL

Viral	NULL
load	NULL
and	NULL
disease	NULL
progression	NULL
in	NULL
infants	NULL
infected	NULL
with	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
.	NULL

N.	NULL
Engl	NULL
.	NULL

J.	NULL
Med	NULL
.	NULL

336:1337	NULL
.	NULL

3	NULL
.	NULL

Cao	NULL
,	NULL
Y.	NULL
,	NULL
P.	NULL
Krogstad	NULL
,	NULL
B.	NULL
Korber	NULL
,	NULL
R.	NULL
Koup	NULL
,	NULL
M.	NULL
Muldoon	NULL
,	NULL
C.	NULL
Macken	NULL
,	NULL
J	NULL
.	NULL

Song	NULL
,	NULL
Z.	NULL
Jin	NULL
,	NULL
J.	NULL
Zhao	NULL
,	NULL
S.	NULL
Clapp	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1997	NULL
.	NULL

Maternal	NULL
HIV-1	NULL
viral	NULL
load	NULL
and	NULL
vertical	NULL
transmission	NULL
of	NULL
infection	NULL
:	NULL
the	NULL
Ariel	NULL
Project	NULL
for	NULL
the	NULL
prevention	NULL
of	NULL
HIV	NULL
transmission	NULL
from	NULL
mother	NULL
to	NULL
infant	NULL
.	NULL

Nat	NULL
.	NULL

Med	NULL
.	NULL

3:549	NULL
.	NULL

4	NULL
.	NULL

Lambert	NULL
,	NULL
G.	NULL
,	NULL
D.	NULL
Thea	NULL
,	NULL
V.	NULL
Pliner	NULL
,	NULL
R.	NULL
Steketee	NULL
,	NULL
E.	NULL
Abrams	NULL
,	NULL
P.	NULL
Matheson	NULL
,	NULL
P.	NULL
Thomas	NULL
,	NULL
B.	NULL
Greenberg	NULL
,	NULL
T.	NULL
Brown	NULL
,	NULL
M.	NULL
Bamji	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1997	NULL
.	NULL

Effect	NULL
of	NULL
maternal	NULL
CD4*	NULL
cell	NULL
count	NULL
,	NULL
acquired	NULL
immunodeficiency	NULL
syndrome	NULL
,	NULL
and	NULL
viral	NULL
load	NULL
on	NULL
dis-case	NULL
progression	NULL
in	NULL
infants	NULL
with	NULL
perinatally	NULL
acquired	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
infection	NULL
.	NULL

J.	NULL
Pediatr	NULL
.	NULL

130:890	NULL
.	NULL

5	NULL
.	NULL

O'Shea	NULL
,	NULL
S.	NULL
,	NULL
M.	NULL
Newell	NULL
,	NULL
D.	NULL
Dunn	NULL
,	NULL
M.	NULL
Garcia-Rodriguez	NULL
,	NULL
I.	NULL
Bates	NULL
,	NULL
J.	NULL
Mullen	NULL
,	NULL
T.	NULL
Rostron	NULL
,	NULL
K.	NULL
Corbett	NULL
,	NULL
S.	NULL
Aiyer	NULL
,	NULL
K.	NULL
Butler	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1998	NULL
.	NULL

Maternal	NULL
viral	NULL
load	NULL
,	NULL
CD4	NULL
cell	NULL
count	NULL
and	NULL
vertical	NULL
transmission	NULL
of	NULL
HIV-1	NULL
.	NULL

J.	NULL
Med	NULL
.	NULL

Virol	NULL
.	NULL

54:113	NULL
.	NULL

6	NULL
.	NULL

Pontesilli	NULL
,	NULL
O.	NULL
,	NULL
M.	NULL
Klein	NULL
,	NULL
S.	NULL
Kerkhof-Garde	NULL
,	NULL
N.	NULL
Pakker	NULL
,	NULL
F.	NULL
de	NULL
Wolf	NULL
,	NULL
H.	NULL
Schuitemaker	NULL
,	NULL
and	NULL
F.	NULL
Miedema	NULL
.	NULL

1997	NULL
.	NULL

Kinetics	NULL
of	NULL
immune	NULL
functions	NULL
and	NULL
virus	NULL
replication	NULL
during	NULL
HIV-1	NULL
infection	NULL
.	NULL

Immunol	NULL
.	NULL

Lett	NULL
.	NULL

57:125	NULL
.	NULL

7	NULL
.	NULL

Fauci	NULL
,	NULL
A	NULL
.	NULL

1996	NULL
.	NULL

Host	NULL
factors	NULL
and	NULL
the	NULL
pathogenesis	NULL
of	NULL
HIV-induced	NULL
disease	NULL
.	NULL

No-ture	NULL
384:529	NULL
.	NULL

8	NULL
.	NULL

Folks	NULL
,	NULL
T.	NULL
M.	NULL
,	NULL
K.	NULL
A.	NULL
Clouse	NULL
,	NULL
J.	NULL
Justement	NULL
,	NULL
A.	NULL
Rabson	NULL
,	NULL
E.	NULL
Duh	NULL
,	NULL
J.	NULL
H.	NULL
Kehrl	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Fauci	NULL
.	NULL

1989	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
induces	NULL
expression	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
in	NULL
chronically	NULL
infected	NULL
T-cell	NULL
clone	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86:2365	NULL
.	NULL

9	NULL
.	NULL

Poli	NULL
,	NULL
G.	NULL
,	NULL
A.	NULL
Kinter	NULL
,	NULL
J.	NULL
Justement	NULL
,	NULL
J.	NULL
Kehrl	NULL
,	NULL
P.	NULL
Bressler	NULL
,	NULL
S.	NULL
Stanley	NULL
,	NULL
and	NULL
A.	NULL
Fauci	NULL
.	NULL

1990	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
functions	NULL
in	NULL
an	NULL
autocrine	NULL
manner	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
expression	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87	NULL
:	NULL
782	NULL
.	NULL

10	NULL
.	NULL

Kriegler	NULL
,	NULL
M.	NULL
,	NULL
C.	NULL
Perez	NULL
,	NULL
K.	NULL
DeFay	NULL
,	NULL
I.	NULL
Albert	NULL
,	NULL
and	NULL
S.	NULL
Lu	NULL
.	NULL

1988	NULL
.	NULL

A	NULL
novel	NULL
form	NULL
of	NULL
TNF/cachectin	NULL
in	NULL
a	NULL
cell	NULL
surface	NULL
cytotoxic	NULL
transmembrane	NULL
protein	NULL
:	NULL
ramifications	NULL
for	NULL
the	NULL
complex	NULL
physiology	NULL
of	NULL
TNF	NULL
.	NULL

Cell	NULL
53:45	NULL
.	NULL

11	NULL
.	NULL

Bazzoni	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
B.	NULL
Beutler	NULL
.	NULL

1995	NULL
.	NULL

How	NULL
do	NULL
tumor	NULL
necrosis	NULL
factor	NULL
receptors	NULL
work	NULL
?	NULL

J.	NULL
Inflamm	NULL
.	NULL

45:221	NULL
.	NULL

12	NULL
.	NULL

Hsu	NULL
,	NULL
H.	NULL
,	NULL
J.	NULL
Xiong	NULL
,	NULL
and	NULL
D.	NULL
V.	NULL
Goeddel	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
TNF	NULL
receptor	NULL
l-associated	NULL
protein	NULL
TRADD	NULL
signals	NULL
cell	NULL
death	NULL
and	NULL
NF-KB	NULL
activation	NULL
.	NULL

Cell	NULL
81:495	NULL
.	NULL

13	NULL
.	NULL

Rothe	NULL
,	NULL
M.	NULL
,	NULL
V.	NULL
Sarma	NULL
,	NULL
V.	NULL
M.	NULL
Dixit	NULL
,	NULL
D.	NULL
V.	NULL
Goeddel	NULL
.	NULL

1995	NULL
.	NULL

TRAF2-mediated	NULL
activation	NULL
of	NULL
NF-kB	NULL
by	NULL
TNF	NULL
receptor	NULL
2	NULL
and	NULL
CD40	NULL
.	NULL

Science	NULL
269:1424	NULL
.	NULL

14	NULL
.	NULL

Engelmann	NULL
,	NULL
H.	NULL
,	NULL
H.	NULL
Holtmann	NULL
,	NULL
C.	NULL
Brakebush	NULL
,	NULL
Y.	NULL
S.	NULL
Avni	NULL
,	NULL
I	NULL
Sarov	NULL
,	NULL
Y.	NULL
Nophar	NULL
,	NULL
E.	NULL
Hadas	NULL
,	NULL
O.	NULL
Leitner	NULL
,	NULL
and	NULL
D.	NULL
Wallach	NULL
.	NULL

1990	NULL
.	NULL

Antibodies	NULL
to	NULL
a	NULL
soluble	NULL
form	NULL
of	NULL
a	NULL
tumor	NULL
necrosis	NULL
factor	NULL
(	NULL
INF	NULL
)	NULL
receptor	NULL
have	NULL
TNF-like	NULL
activity	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

265:14497	NULL
.	NULL

15	NULL
.	NULL

Espevik	NULL
,	NULL
T.	NULL
,	NULL
M.	NULL
Brockhaus	NULL
,	NULL
H.	NULL
Loetscher	NULL
,	NULL
U.	NULL
Nonstad	NULL
,	NULL
and	NULL
R.	NULL
Shalaby	NULL
.	NULL

1990	NULL
.	NULL

Characterization	NULL
of	NULL
binding	NULL
and	NULL
biological	NULL
effects	NULL
of	NULL
monoclonal	NULL
antibodies	NULL
against	NULL
a	NULL
human	NULL
tumor	NULL
necrosis	NULL
factor	NULL
receptor	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

171:415	NULL
.	NULL

16	NULL
.	NULL

Grell	NULL
,	NULL
M.	NULL
,	NULL
H.	NULL
Douni	NULL
,	NULL
M.	NULL
Wajant	NULL
,	NULL
M.	NULL
Lohden	NULL
,	NULL
M.	NULL
Clauss	NULL
,	NULL
B.	NULL
Maxciner	NULL
,	NULL
S.	NULL
Georgopoulos	NULL
,	NULL
W.	NULL
Lesslauer	NULL
,	NULL
G.	NULL
Kollias	NULL
,	NULL
K.	NULL
Pfizenmaier	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
transmembrane	NULL
form	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor	NULL
is	NULL
the	NULL
prime	NULL
activating	NULL
ligand	NULL
of	NULL
the	NULL
80	NULL
kDa	NULL
TNF	NULL
receptor	NULL
.	NULL

Cell	NULL
83:793	NULL
.	NULL

17	NULL
.	NULL

Matsumoto	NULL
,	NULL
M.	NULL
Y.-X	NULL
.	NULL

Fu	NULL
,	NULL
H.	NULL
Molina	NULL
,	NULL
and	NULL
D.	NULL
Chaplin	NULL
.	NULL

1997	NULL
.	NULL

Lymphotoxin-a-deficient	NULL
and	NULL
TNF	NULL
receptor-I-deficient	NULL
mice	NULL
define	NULL
developmental	NULL
and	NULL
functional	NULL
characteristics	NULL
of	NULL
germinal	NULL
centers	NULL
.	NULL

Immunol	NULL
.	NULL

Rev	NULL
.	NULL

156:137	NULL
.	NULL

18	NULL
.	NULL

MacKay	NULL
,	NULL
F.	NULL
,	NULL
G.	NULL
Majeau	NULL
,	NULL
P.	NULL
Lawton	NULL
,	NULL
P.	NULL
Hochman	NULL
,	NULL
and	NULL
J.	NULL
Browning	NULL
.	NULL

1997	NULL
.	NULL

Lymphotoxin	NULL
but	NULL
not	NULL
tumor	NULL
necrosis	NULL
factor	NULL
functions	NULL
to	NULL
maintain	NULL
splenic	NULL
architecture	NULL
and	NULL
humoral	NULL
responsiveness	NULL
in	NULL
adult	NULL
mice	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

27:2033	NULL
.	NULL

19	NULL
.	NULL

Rennart	NULL
,	NULL
P.	NULL
,	NULL
J.	NULL
Browning	NULL
,	NULL
R.	NULL
Mebius	NULL
,	NULL
F.	NULL
Mackay	NULL
,	NULL
and	NULL
P.	NULL
Hochman	NULL
.	NULL

1996	NULL
.	NULL

Surface	NULL
lymphotoxin	NULL
a/	NULL
complex	NULL
is	NULL
required	NULL
for	NULL
the	NULL
development	NULL
of	NULL
peripheral	NULL
lymphoid	NULL
organs	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

184:1999	NULL
.	NULL

20	NULL
.	NULL

Murphy	NULL
,	NULL
M.	NULL
,	NULL
B.	NULL
N.	NULL
Walter	NULL
,	NULL
L.	NULL
Pike-Noble	NULL
,	NULL
N.	NULL
A.	NULL
Fanger	NULL
,	NULL
P.	NULL
Guyre	NULL
,	NULL
J.	NULL
L.	NULL
Browning	NULL
,	NULL
C.	NULL
F.	NULL
Ware	NULL
,	NULL
and	NULL
L.	NULL
B.	NULL
Epstein	NULL
.	NULL

1998	NULL
.	NULL

Expression	NULL
of	NULL
lymphotoxin-B	NULL
receptor	NULL
on	NULL
follicular	NULL
stromal	NULL
cells	NULL
in	NULL
human	NULL
lymphoid	NULL
tissues	NULL
.	NULL

Cell	NULL
Death	NULL
Differ	NULL
.	NULL

5:497	NULL
.	NULL

21	NULL
.	NULL

Chaplin	NULL
,	NULL
D.	NULL
D.	NULL
,	NULL
and	NULL
Y.-X	NULL
.	NULL

Fu	NULL
.	NULL

1998	NULL
.	NULL

Cytokine	NULL
regulation	NULL
of	NULL
secondary	NULL
lymphoid	NULL
organ	NULL
development	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

10:289	NULL
.	NULL

22	NULL
.	NULL

MacKay	NULL
,	NULL
F.	NULL
,	NULL
and	NULL
J.	NULL
L.	NULL
Browning	NULL
.	NULL

1998	NULL
.	NULL

Turning	NULL
off	NULL
follicular	NULL
dendritic	NULL
cells	NULL
.	NULL

Nature	NULL
395:26	NULL
.	NULL

23	NULL
.	NULL

Mauri	NULL
,	NULL
D.	NULL
,	NULL
R.	NULL
Ebner	NULL
,	NULL
R.	NULL
Montgomery	NULL
,	NULL
K.	NULL
Kochel	NULL
,	NULL
T.	NULL
Cheung	NULL
,	NULL
G.	NULL
L.	NULL
Yu	NULL
,	NULL
S.	NULL
Ruben	NULL
,	NULL
M.	NULL
Murphy	NULL
,	NULL
R.	NULL
Eisenberg	NULL
,	NULL
G.	NULL
Cohen	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1998	NULL
.	NULL

LIGHT	NULL
,	NULL
a	NULL
new	NULL
member	NULL
of	NULL
the	NULL
TNF	NULL
superfamily	NULL
,	NULL
and	NULL
lymphotoxin-a	NULL
are	NULL
ligands	NULL
for	NULL
herpesvirus	NULL
entry	NULL
mediator	NULL
.	NULL

Immunity	NULL
8:21	NULL
.	NULL

24	NULL
.	NULL

Marino	NULL
,	NULL
M.	NULL
,	NULL
A.	NULL
Dunn	NULL
,	NULL
D.	NULL
Grail	NULL
,	NULL
M.	NULL
Ingleses	NULL
,	NULL
Y.	NULL
Noguchi	NULL
,	NULL
E.	NULL
Richards	NULL
,	NULL
A.	NULL
Jungbluth	NULL
,	NULL
H.	NULL
Wada	NULL
,	NULL
M.	NULL
Moore	NULL
,	NULL
B.	NULL
Williamson	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1997	NULL
.	NULL

Characterization	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor-deficient	NULL
mice	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
94:8093	NULL
.	NULL

25	NULL
.	NULL

Pasparakis	NULL
,	NULL
M.	NULL
,	NULL
L.	NULL
Alexopoulou	NULL
,	NULL
V.	NULL
Episkopou	NULL
,	NULL
and	NULL
G.	NULL
Kollias	NULL
.	NULL

1996	NULL
.	NULL

Immune	NULL
and	NULL
inflammatory	NULL
responses	NULL
in	NULL
TNF-a	NULL
deficient	NULL
mice	NULL
:	NULL
a	NULL
critical	NULL
requirement	NULL
for	NULL
TNF	NULL
in	NULL
germinal	NULL
center	NULL
formation	NULL
and	NULL
in	NULL
the	NULL
maturation	NULL
of	NULL
the	NULL
humoral	NULL
immune	NULL
response	NULL
.	NULL

Eur	NULL
.	NULL

Cytokine	NULL
Netw	NULL
.	NULL

7:227	NULL
.	NULL

26	NULL
.	NULL

Cook	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
H.	NULL
Komer	NULL
,	NULL
D.	NULL
S.	NULL
Riminton	NULL
,	NULL
F.	NULL
A.	NULL
Lemckert	NULL
,	NULL
J.	NULL
Hasbold	NULL
,	NULL
M.	NULL
Amesbury	NULL
,	NULL
P.	NULL
D.	NULL
Hodgkin	NULL
,	NULL
J.	NULL
G.	NULL
Cyster	NULL
,	NULL
J.	NULL
D.	NULL
Sedgwick	NULL
,	NULL
and	NULL
A.	NULL
Basten	NULL
.	NULL

1998	NULL
.	NULL

Generation	NULL
of	NULL
splenic	NULL
follicular	NULL
structure	NULL
and	NULL
B	NULL
cell	NULL
movement	NULL
in	NULL
tumor	NULL
necrosis	NULL
factor-deficient	NULL
mice	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

188:1503	NULL
.	NULL

27	NULL
.	NULL

Le	NULL
Hir	NULL
,	NULL
M.	NULL
,	NULL
H.	NULL
Bluethmann	NULL
,	NULL
M.	NULL
Kosco-Vilbois	NULL
,	NULL
M.	NULL
Muller	NULL
,	NULL
F.	NULL
di	NULL
Padova	NULL
,	NULL
M.	NULL
Moore	NULL
,	NULL
B.	NULL
Ryffel	NULL
,	NULL
and	NULL
H.-P.	NULL
Eugster	NULL
.	NULL

1996	NULL
.	NULL

Differentiation	NULL
of	NULL
follicular	NULL
dendritic	NULL
cells	NULL
and	NULL
full	NULL
antibody	NULL
responses	NULL
require	NULL
tumor	NULL
necrosis	NULL
factor	NULL
receptor-1	NULL
signaling	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

183:2367	NULL
.	NULL

28	NULL
.	NULL

Boussiotis	NULL
,	NULL
V.	NULL
A.	NULL
,	NULL
L.	NULL
Nadler	NULL
,	NULL
J.	NULL
L.	NULL
Strominger	NULL
,	NULL
and	NULL
A.	NULL
E.	NULL
Goldfeld	NULL
.	NULL

1994	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor-a	NULL
is	NULL
an	NULL
autocrine	NULL
growth	NULL
factor	NULL
for	NULL
activated	NULL
B	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91:7007	NULL
.	NULL

29	NULL
.	NULL

Cajigas	NULL
,	NULL
A.	NULL
,	NULL
M.	NULL
Subrland	NULL
,	NULL
C.	NULL
Harris	NULL
,	NULL
F.	NULL
Chu	NULL
,	NULL
J.	NULL
McGowan	NULL
,	NULL
M.	NULL
Golodner	NULL
,	NULL
A.	NULL
Seymour	NULL
,	NULL
and	NULL
W.	NULL
Lyman	NULL
.	NULL

1997	NULL
.	NULL

Correlation	NULL
of	NULL
the	NULL
ratio	NULL
of	NULL
CD4	NULL
*/CD8*	NULL
cells	NULL
in	NULL
lymph	NULL
node	NULL
fine	NULL
needle	NULL
aspiration	NULL
biopsies	NULL
with	NULL
HIV	NULL
clinical	NULL
status	NULL
:	NULL
a	NULL
preliminary	NULL
study	NULL
.	NULL

Acta	NULL
Cytolog	NULL
.	NULL

41:1762	NULL
.	NULL

30	NULL
.	NULL

Haase	NULL
,	NULL
A.	NULL
,	NULL
K.	NULL
Henry	NULL
,	NULL
M.	NULL
Zupanic	NULL
,	NULL
G.	NULL
Sedgwick	NULL
,	NULL
R.	NULL
Faust	NULL
,	NULL
H.	NULL
Melroc	NULL
,	NULL
W.	NULL
Cavert	NULL
,	NULL
K.	NULL
Gebhard	NULL
,	NULL
K.	NULL
Staskus	NULL
,	NULL
Z.-Q	NULL
.	NULL

Zhang	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1996	NULL
.	NULL

Quantitative	NULL
image	NULL
analysis	NULL
of	NULL
HIV-1	NULL
infection	NULL
in	NULL
lymphoid	NULL
tissue	NULL
.	NULL

Science	NULL
274:985	NULL
.	NULL

31	NULL
.	NULL

Embertson	NULL
,	NULL
J.	NULL
,	NULL
M.	NULL
Zupancic	NULL
,	NULL
J.	NULL
L.	NULL
Ribas	NULL
,	NULL
A.	NULL
Burke	NULL
,	NULL
P.	NULL
Racz	NULL
,	NULL
K.	NULL
Tenner-Racz	NULL
,	NULL
and	NULL
A.	NULL
Haase	NULL
.	NULL

1993	NULL
.	NULL

Massive	NULL
covert	NULL
infection	NULL
of	NULL
helper	NULL
T	NULL
lymphocytes	NULL
and	NULL
macro-phages	NULL
by	NULL
HIV	NULL
during	NULL
the	NULL
incubation	NULL
period	NULL
of	NULL
AIDS	NULL
.	NULL

Nature	NULL
362:359	NULL
.	NULL

32	NULL
.	NULL

Balter	NULL
,	NULL
M.	NULL
1996	NULL
.	NULL

HIV	NULL
's	NULL
other	NULL
immune	NULL
system	NULL
targets	NULL
:	NULL
macrophages	NULL
.	NULL

Science	NULL
274	NULL
;	NULL
1464	NULL
.	NULL

33	NULL
.	NULL

Griffin	NULL
,	NULL
G.	NULL
E.	NULL
,	NULL
K.	NULL
Leung	NULL
,	NULL
T.	NULL
M.	NULL
Folks	NULL
,	NULL
S.	NULL
Kunkel	NULL
,	NULL
and	NULL
G.	NULL
Nabel	NULL
.	NULL

1989	NULL
.	NULL

Activation	NULL
of	NULL
HIV	NULL
gene	NULL
expression	NULL
during	NULL
monocyte	NULL
differentiation	NULL
by	NULL
induction	NULL
of	NULL
NF-KB	NULL
.	NULL

Nature	NULL
339:70	NULL
.	NULL

34	NULL
.	NULL

Folks	NULL
,	NULL
T.	NULL
,	NULL
J.	NULL
Justement	NULL
,	NULL
C.	NULL
Dinarello	NULL
,	NULL
and	NULL
A.	NULL
Fauci	NULL
.	NULL

1987	NULL
.	NULL

Cytokine-induced	NULL
expression	NULL
of	NULL
HIV-1	NULL
in	NULL
a	NULL
chronically	NULL
infected	NULL
promonocyte	NULL
cell	NULL
line	NULL
.	NULL

Science	NULL
238	NULL
:	NULL
800	NULL
.	NULL

35	NULL
.	NULL

Marshall	NULL
,	NULL
W.	NULL
,	NULL
D.	NULL
Diamond	NULL
,	NULL
M.	NULL
Kowalski	NULL
,	NULL
and	NULL
R.	NULL
Finberg	NULL
.	NULL

1992	NULL
.	NULL

High	NULL
level	NULL
of	NULL
surface	NULL
CD4	NULL
prevents	NULL
stable	NULL
HIV	NULL
infection	NULL
of	NULL
T	NULL
cell	NULL
transfectants	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

66	NULL
:	NULL
5492	NULL
.	NULL

36	NULL
.	NULL

Marshall	NULL
,	NULL
W.	NULL
L.	NULL
,	NULL
E.S	NULL
.	NULL

Mittler	NULL
,	NULL
P.	NULL
Avery	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Lawrence	NULL
,	NULL
and	NULL
R.	NULL
W.	NULL
Finberg	NULL
.	NULL

1994	NULL
.	NULL

Glycosylphosphatidylinositol-anchored	NULL
CD4	NULL
supports	NULL
HIV-1	NULL
replication	NULL
,	NULL
but	NULL
not	NULL
cytopathic	NULL
effect	NULL
,	NULL
in	NULL
T	NULL
cell	NULL
transfectants	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

68:4039	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49.	NULL
.	NULL

Nakano	NULL
,	NULL
H.	NULL
,	NULL
H.	NULL
Oshima	NULL
,	NULL
W.	NULL
Chung	NULL
,	NULL
L.	NULL
Williams-Abbott	NULL
,	NULL
C.	NULL
Ware	NULL
,	NULL
H.	NULL
Yagita	NULL
,	NULL
and	NULL
51	NULL
.	NULL

Browning	NULL
,	NULL
J.	NULL
,	NULL
I.	NULL
Dougas	NULL
,	NULL
A.	NULL
Ngam-ek	NULL
,	NULL
P.	NULL
Bourdon	NULL
,	NULL
B.	NULL
Ehrenfels	NULL
,	NULL
K.	NULL
Miatowski	NULL
,	NULL
M.	NULL
Zafari	NULL
,	NULL
A.	NULL
Yampaglia	NULL
,	NULL
P.	NULL
Lawton	NULL
,	NULL
W.	NULL
Meier	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1995	NULL
.	NULL

Characterization	NULL
of	NULL
surface	NULL
lymphotoxin	NULL
forms	NULL
:	NULL
use	NULL
of	NULL
specific	NULL
antibodies	NULL
and	NULL
soluble	NULL
receptors	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

154:33	NULL
.	NULL

Browning	NULL
,	NULL
J.	NULL
,	NULL
K.	NULL
Miatkowski	NULL
,	NULL
D.	NULL
Griffiths	NULL
,	NULL
P.	NULL
Bourdon	NULL
,	NULL
C.	NULL
Hession	NULL
,	NULL
C.	NULL
Ambrose	NULL
,	NULL
and	NULL
W.	NULL
Meier	NULL
.	NULL

1996	NULL
.	NULL

Preparation	NULL
and	NULL
characterization	NULL
of	NULL
soluble	NULL
recombinant	NULL
heterotrimeric	NULL
complexes	NULL
of	NULL
human	NULL
lymphotoxins	NULL
a	NULL
and	NULL
B.	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271	NULL
:	NULL
8618	NULL
.	NULL

Browning	NULL
,	NULL
J.	NULL
,	NULL
K.	NULL
Miatkowski	NULL
,	NULL
I.	NULL
Sizing	NULL
,	NULL
D.	NULL
Griffiths	NULL
,	NULL
M.	NULL
Zafari	NULL
,	NULL
C.	NULL
Benjamin	NULL
,	NULL
W.	NULL
Meier	NULL
,	NULL
and	NULL
F.	NULL
MacKay	NULL
.	NULL

1996	NULL
.	NULL

Signaling	NULL
through	NULL
the	NULL
receptor	NULL
induces	NULL
the	NULL
death	NULL
of	NULL
some	NULL
adenocarcinoma	NULL
tumor	NULL
cell	NULL
lines	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

183	NULL
;	NULL
867	NULL
.	NULL

Brockhaus	NULL
,	NULL
M.	NULL
,	NULL
H.	NULL
Schoenfeld	NULL
,	NULL
E.	NULL
Schlaeger	NULL
,	NULL
W.	NULL
Hunziker	NULL
,	NULL
W.	NULL
Lesslauer	NULL
,	NULL
and	NULL
H.	NULL
Loctscher	NULL
.	NULL

1990	NULL
.	NULL

Identification	NULL
of	NULL
two	NULL
types	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor	NULL
receptors	NULL
on	NULL
human	NULL
cell	NULL
lines	NULL
by	NULL
monoclonal	NULL
antibodies	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87	NULL
:	NULL
3127	NULL
.	NULL

Bergelson	NULL
,	NULL
J.	NULL
,	NULL
M.	NULL
Shepley	NULL
,	NULL
B.	NULL
Chan	NULL
,	NULL
M.	NULL
Hemler	NULL
,	NULL
and	NULL
R.	NULL
Finberg	NULL
.	NULL

1992	NULL
.	NULL

Identification	NULL
of	NULL
the	NULL
integrin	NULL
VLA-2	NULL
as	NULL
a	NULL
receptor	NULL
for	NULL
echovirus	NULL
1	NULL
.	NULL

Science	NULL
255:1718	NULL
.	NULL

Tsitsikov	NULL
,	NULL
E.	NULL
,	NULL
R.	NULL
Fuleihan	NULL
,	NULL
K.	NULL
Mcintosh	NULL
,	NULL
P.	NULL
Scholl	NULL
,	NULL
and	NULL
R.	NULL
Geha	NULL
.	NULL

1995	NULL
.	NULL

Cross-linking	NULL
of	NULL
Foy	NULL
receptors	NULL
activates	NULL
HIV-1	NULL
long	NULL
terminal	NULL
repeat-driven	NULL
transcription	NULL
in	NULL
human	NULL
monocytes	NULL
.	NULL

Int	NULL
.	NULL

Immunol	NULL
.	NULL

7:1665	NULL
.	NULL

Matsuyama	NULL
,	NULL
T.	NULL
,	NULL
A.	NULL
Yamada	NULL
,	NULL
J.	NULL
Kay	NULL
,	NULL
K.	NULL
Yamada	NULL
,	NULL
S.	NULL
Akiyama	NULL
,	NULL
S.	NULL
Schlossman	NULL
,	NULL
and	NULL
C.	NULL
Morimoto	NULL
.	NULL

1989	NULL
.	NULL

Activation	NULL
of	NULL
CD4	NULL
cells	NULL
by	NULL
fibronectin	NULL
and	NULL
anti-CD3	NULL
anti-body	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

170:1133.	NULL
.	NULL

Goldfeld	NULL
,	NULL
A.	NULL
E.	NULL
,	NULL
P.	NULL
G.	NULL
McCaffrey	NULL
,	NULL
J.	NULL
L.	NULL
Strominger	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1993	NULL
.	NULL

Identifi-	NULL
cation	NULL
of	NULL
a	NULL
novel	NULL
cyclosporin-sensitive	NULL
element	NULL
in	NULL
the	NULL
human	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
gene	NULL
promoter	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

178:1365	NULL
.	NULL

Chicheportiche	NULL
,	NULL
Y.	NULL
,	NULL
P.	NULL
Bourdon	NULL
,	NULL
H.	NULL
Xu	NULL
,	NULL
Y.	NULL
Hsu	NULL
,	NULL
H.	NULL
Scott	NULL
,	NULL
C.	NULL
Hession	NULL
,	NULL
I.	NULL
Garcia	NULL
,	NULL
and	NULL
J.	NULL
Browning	NULL
.	NULL

1997	NULL
.	NULL

TWEAK	NULL
,	NULL
a	NULL
new	NULL
secreted	NULL
ligand	NULL
in	NULL
the	NULL
tumor	NULL
necrosis	NULL
factor	NULL
family	NULL
that	NULL
weakly	NULL
induces	NULL
apoptosis	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272:32401	NULL
.	NULL

Crowe	NULL
,	NULL
P.	NULL
,	NULL
T.	NULL
VanArsdale	NULL
,	NULL
B.	NULL
Walter	NULL
,	NULL
C.	NULL
Ware	NULL
,	NULL
C.	NULL
Hession	NULL
,	NULL
B.	NULL
Ehrenfels	NULL
,	NULL
J.	NULL
Browning	NULL
,	NULL
W.	NULL
Din	NULL
,	NULL
R.	NULL
Goodwin	NULL
,	NULL
and	NULL
C.	NULL
Smith	NULL
.	NULL

1994	NULL
.	NULL

A	NULL
lymphotoxin-B-spe-cific	NULL
receptor	NULL
.	NULL

Science	NULL
264:707	NULL
.	NULL

Nicoletti	NULL
,	NULL
L.	NULL
,	NULL
G.	NULL
Migliorati	NULL
,	NULL
M.	NULL
C.	NULL
Pagliace	NULL
,	NULL
F.	NULL
Grignani	NULL
,	NULL
and	NULL
C.	NULL
Riccardi	NULL
.	NULL

1991	NULL
.	NULL

A	NULL
rapid	NULL
and	NULL
simple	NULL
method	NULL
for	NULL
measuring	NULL
thymocyte	NULL
apoptosis	NULL
by	NULL
propidium	NULL
iodide	NULL
staining	NULL
and	NULL
flow	NULL
cytometry	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

Methods	NULL
139:271	NULL
.	NULL

Mackay	NULL
,	NULL
F.	NULL
,	NULL
G.	NULL
Majeau	NULL
,	NULL
P.	NULL
Hochman	NULL
,	NULL
and	NULL
J.	NULL
Browning	NULL
.	NULL

1996	NULL
.	NULL

Lymphotoxin	NULL
B	NULL
receptor	NULL
triggering	NULL
induces	NULL
activation	NULL
of	NULL
the	NULL
nuclear	NULL
factor	NULL
«	NULL
B	NULL
transcription	NULL
factor	NULL
in	NULL
some	NULL
cell	NULL
types	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:24934	NULL
.	NULL

Thanos	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
T.	NULL
Maniatis	NULL
.	NULL

1995	NULL
.	NULL

NF-KB	NULL
:	NULL
a	NULL
lesson	NULL
in	NULL
family	NULL
value	NULL
.	NULL

Cell	NULL
80:529	NULL
.	NULL

K.	NULL
Okumura	NULL
.	NULL

1996	NULL
.	NULL

TRAFS5	NULL
,	NULL
an	NULL
activator	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
putative	NULL
signal	NULL
transducer	NULL
for	NULL
the	NULL
lymphotoxin-B	NULL
receptor	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271:14661	NULL
.	NULL

Deng	NULL
,	NULL
H.	NULL
,	NULL
R.	NULL
Liu	NULL
,	NULL
W.	NULL
Ellimeier	NULL
,	NULL
S.	NULL
Choe	NULL
,	NULL
D.	NULL
Unutmaz	NULL
,	NULL
M.	NULL
Burkhart	NULL
,	NULL
P.	NULL
Marxio	NULL
,	NULL
S.	NULL
Marmon	NULL
,	NULL
R.	NULL
Sutton	NULL
,	NULL
C.	NULL
Hill	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1996	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
major	NULL
coreceptor	NULL
for	NULL
primary	NULL
isolates	NULL
of	NULL
HIV-1	NULL
.	NULL

Nature	NULL
381:661	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

60	NULL
.	NULL

61	NULL
.	NULL

62	NULL
.	NULL

63	NULL
.	NULL

65	NULL
.	NULL

6023	NULL
Rucker	NULL
,	NULL
J.	NULL
,	NULL
M.	NULL
Samson	NULL
,	NULL
B.	NULL
Doranz	NULL
,	NULL
F.	NULL
Libert	NULL
,	NULL
J.	NULL
Berson	NULL
,	NULL
Y	NULL
.	NULL

Yo	NULL
.	NULL

,	NULL
R.	NULL
Smyth	NULL
,	NULL
R.	NULL
Collman	NULL
,	NULL
C.	NULL
Broder	NULL
,	NULL
G.	NULL
Vassart	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1996	NULL
.	NULL

Regions	NULL
in	NULL
B-chemokine	NULL
receptors	NULL
CCRS	NULL
and	NULL
CCR2b	NULL
that	NULL
determine	NULL
HIV-1	NULL
cofactor	NULL
specificity	NULL
.	NULL

Cell	NULL
87:437	NULL
.	NULL

Rottman	NULL
,	NULL
J.	NULL
,	NULL
K.	NULL
Ganley	NULL
,	NULL
K.	NULL
Williams	NULL
,	NULL
L.	NULL
Wu	NULL
,	NULL
C.	NULL
Mackay	NULL
,	NULL
and	NULL
D.	NULL
Ringler	NULL
.	NULL

1997	NULL
.	NULL

Cellular	NULL
localization	NULL
of	NULL
the	NULL
chemokine	NULL
receptor	NULL
CCRS	NULL
.	NULL

Correlation	NULL
to	NULL
cellular	NULL
targets	NULL
of	NULL
HIV-1	NULL
infection	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Pathol	NULL
.	NULL

151:1341	NULL
.	NULL

Pinchuk	NULL
,	NULL
L.	NULL
,	NULL
P.	NULL
Polacino	NULL
,	NULL
M.	NULL
Agy	NULL
,	NULL
S.	NULL
Klaus	NULL
,	NULL
and	NULL
E.	NULL
Clark	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
role	NULL
of	NULL
CD40	NULL
and	NULL
CD80	NULL
accessory	NULL
cell	NULL
molecules	NULL
in	NULL
dendritic	NULL
cell-dependent	NULL
HIV-1	NULL
infection	NULL
.	NULL

Immunity	NULL
1:317	NULL
.	NULL

Mackay	NULL
,	NULL
F.	NULL
,	NULL
P.	NULL
Bourdon	NULL
,	NULL
D.	NULL
Griffiths	NULL
,	NULL
P.	NULL
Lawton	NULL
,	NULL
M.	NULL
Zafari	NULL
,	NULL
L	NULL
Sizing	NULL
,	NULL
K.	NULL
Miatkowski	NULL
,	NULL
A.	NULL
Ngam-ck	NULL
,	NULL
C.	NULL
Benjamin	NULL
,	NULL
C.	NULL
Hession	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1997	NULL
.	NULL

Cytotoxic	NULL
activities	NULL
of	NULL
recombinant	NULL
soluble	NULL
murine	NULL
lymphotoxin-a	NULL
and	NULL
lymphotoxin-w/B	NULL
complexes	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

159:3299	NULL
.	NULL

Mosialos	NULL
,	NULL
G.	NULL
,	NULL
M.	NULL
Birkenbach	NULL
,	NULL
R.	NULL
Yalamanchili	NULL
,	NULL
T.	NULL
Van	NULL
Arsdale	NULL
,	NULL
C.	NULL
Ware	NULL
,	NULL
and	NULL
E.	NULL
Kieff	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
Epstein-Barr	NULL
virus	NULL
transforming	NULL
protein	NULL
LMP1	NULL
engages	NULL
signaling	NULL
proteins	NULL
for	NULL
the	NULL
tumor	NULL
necrosis	NULL
factor	NULL
receptor	NULL
family	NULL
.	NULL

Cell	NULL
80:389	NULL
.	NULL

Liu	NULL
,	NULL
Z.	NULL
G.	NULL
,	NULL
H.	NULL
Hsu	NULL
,	NULL
D.	NULL
V.	NULL
Goeddel	NULL
,	NULL
and	NULL
M.	NULL
Karin	NULL
.	NULL

1996	NULL
.	NULL

Dissection	NULL
of	NULL
TNF	NULL
receptor	NULL
1	NULL
effector	NULL
functions	NULL
:	NULL
JNK	NULL
activation	NULL
is	NULL
not	NULL
linked	NULL
to	NULL
apoptosis	NULL
while	NULL
NF-KB	NULL
activation	NULL
prevents	NULL
cell	NULL
death	NULL
.	NULL

Cell	NULL
87:565	NULL
.	NULL

Declereq	NULL
,	NULL
W.	NULL
,	NULL
G.	NULL
Denecker	NULL
,	NULL
W.	NULL
Fiers	NULL
,	NULL
and	NULL
P.	NULL
Vandenabeele	NULL
.	NULL

1998	NULL
.	NULL

Cooperation	NULL
of	NULL
both	NULL
TNF	NULL
receptors	NULL
in	NULL
inducing	NULL
apoptosis	NULL
:	NULL
involvement	NULL
of	NULL
the	NULL
TNF	NULL
receptor-associated	NULL
factor	NULL
binding	NULL
domain	NULL
of	NULL
the	NULL
TNF	NULL
receptor	NULL
75	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

161:390	NULL
.	NULL

Lazdins	NULL
,	NULL
J.	NULL
,	NULL
M.	NULL
Grell	NULL
,	NULL
M.	NULL
Walker	NULL
,	NULL
K.	NULL
Woods-Cook	NULL
,	NULL
P.	NULL
Scheurich	NULL
,	NULL
and	NULL
K.	NULL
Pfizenmaier	NULL
.	NULL

1997	NULL
.	NULL

Membrane	NULL
tumor	NULL
necrosis	NULL
factor	NULL
(	NULL
LNF	NULL
)	NULL
induced	NULL
cooperative	NULL
signaling	NULL
of	NULL
TNFR60	NULL
and	NULL
TNFR80	NULL
favors	NULL
induction	NULL
of	NULL
cell	NULL
death	NULL
rather	NULL
than	NULL
virus	NULL
production	NULL
in	NULL
HIV-infected	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

185:81	NULL
.	NULL

Said	NULL
,	NULL
J	NULL
.	NULL

1997	NULL
.	NULL

Humman	NULL
immunodeficiency	NULL
virus-related	NULL
lymphoid	NULL
proliferations	NULL
.	NULL

Semin	NULL
.	NULL

Diag	NULL
.	NULL

Pathol	NULL
.	NULL

14:48	NULL
.	NULL

Amadori	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
L.	NULL
Chieco-Bianchi	NULL
.	NULL

1990	NULL
.	NULL

B-cell	NULL
activation	NULL
and	NULL
HIV-1	NULL
infection	NULL
:	NULL
deeds	NULL
and	NULL
misdeeds	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
374	NULL
.	NULL

Terpstra	NULL
,	NULL
F.	NULL
G.	NULL
,	NULL
B.	NULL
J.	NULL
Al	NULL
,	NULL
M.	NULL
T.	NULL
L.	NULL
Roos	NULL
,	NULL
F.	NULL
DeWolf	NULL
,	NULL
J.	NULL
Goudsmit	NULL
,	NULL
P.	NULL
T.	NULL
A.	NULL
Schellekens	NULL
,	NULL
and	NULL
F.	NULL
Miedema	NULL
.	NULL

1989	NULL
.	NULL

Longitudinal	NULL
study	NULL
of	NULL
leukocyte	NULL
functions	NULL
in	NULL
homosexual	NULL
men	NULL
seroconverted	NULL
for	NULL
HIV	NULL
:	NULL
rapid	NULL
and	NULL
persistent	NULL
loss	NULL
of	NULL
B	NULL
cell	NULL
function	NULL
after	NULL
HIV	NULL
infection	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

19:667	NULL
.	NULL

Mizuma	NULL
,	NULL
H.	NULL
,	NULL
S.	NULL
Litwin	NULL
,	NULL
and	NULL
S.	NULL
Zolla-Pazner	NULL
.	NULL

1988	NULL
.	NULL

B-cell	NULL
activation	NULL
in	NULL
HIV	NULL
infection	NULL
:	NULL
relationship	NULL
of	NULL
spontancous	NULL
immunoglobulin	NULL
secretion	NULL
to	NULL
various	NULL
immu-nological	NULL
parameters	NULL
.	NULL

Clin	NULL
.	NULL

Exp	NULL
.	NULL

Immunol	NULL
.	NULL

71:410.	NULL
.	NULL

Finkel	NULL
,	NULL
T.	NULL
,	NULL
G.	NULL
Tudor-Williams	NULL
,	NULL
N.	NULL
Banda	NULL
,	NULL
M.	NULL
Cotton	NULL
,	NULL
T.	NULL
Curiel	NULL
,	NULL
C.	NULL
Monks	NULL
,	NULL
T.	NULL
Baba	NULL
,	NULL
R.	NULL
Ruprecht	NULL
,	NULL
and	NULL
A.	NULL
Kupfer	NULL
.	NULL

1995	NULL
.	NULL

Apoptosis	NULL
occurs	NULL
predominantly	NULL
in	NULL
bystander	NULL
cells	NULL
and	NULL
not	NULL
in	NULL
productively	NULL
infected	NULL
cells	NULL
of	NULL
HIV-	NULL
and	NULL
SIV-infected	NULL
lymph	NULL
nodes	NULL
.	NULL

Nat	NULL
.	NULL

Med	NULL
.	NULL

1:129	NULL
.	NULL

Pantaleo	NULL
,	NULL
G.	NULL
,	NULL
C.	NULL
Graziosi	NULL
,	NULL
J.	NULL
F.	NULL
Demarest	NULL
,	NULL
L.	NULL
Butini	NULL
,	NULL
M.	NULL
Montroni	NULL
,	NULL
C.	NULL
H.	NULL
Fox	NULL
,	NULL
J.	NULL
M.	NULL
Orenstein	NULL
,	NULL
D.	NULL
P.	NULL
Kotler	NULL
,	NULL
and	NULL
A.	NULL
S.	NULL
Fauci	NULL
.	NULL

1993	NULL
.	NULL

HIV	NULL
infection	NULL
is	NULL
active	NULL
and	NULL
progressive	NULL
in	NULL
lymphoid	NULL
tissue	NULL
during	NULL
the	NULL
clinically	NULL
latent	NULL
stage	NULL
of	NULL
disease	NULL
.	NULL

Nature	NULL
362:355	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL

